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K channel oscillations in spontaneously migrating transformed
MUCK cells. A. Schwab, H-f. Westphale, L. Wojnowski, S. Whnsch,
and H. Oberleithner, Physiologisches Institut, Wurzburg, Germany.
Alkali-transformed MDCK cells have a spontaneously oscillating cell
membrane potential (PD) and they are constantly migrating over their
growth support. Using single channel patch clamp technique and
interference contrast microscopy we studied the K channel underlying
the oscillating PD and its possible role in cell migration. We identified a
Ca2 sensitive K channel (conductances of 53 3 pS and 27 5 pS
for inward and outward current). In contrast to normal MDCK cells we
find oscillations of its activity in the cell-attached patch mode. They
have the same frequency as oscillations of the PD. In the inside-out
patch mode channel open probability is half maximal at 10 tLM Ca21 in
the bath. The K channel has almost identical properties (conductance,
selectivity, kinetic) as the K channel from normal MDCK cells.
Hence, the oscillating PD is due to altered channel regulators and not
due to modified channel properties. Transformed MDCK cells are
migrating at a rate of 0.9 m/min. After application of the K channel
blocker Ba2 (1 or 5 mmol/liter) "forward" migration is slowed down or
stopped. This is consistent with K channels being involved in migra-
tion.
Depolarization of freshly isolated thick ascending limb (TAL) cells of
rat kidney by ammonium via inhibition of a pH sensitive K-channel. M.
Bleich, E. Schiatter, R. Greger, and P. Schollmeyer, Physiologisches
Institut, Medizinische Klinik, Universitlit Freiburg, Freiburg, Ger-
many. The luminal membrane of the TAL is highly K conductive.
Patch-clamp studies on isolated perfused TAL tubules have identified
an intermediate K channel regulated by cytosolic pH. To perform slow
whole-cell (SWC) and cell-attached-nystatin (CAN) experiments on
both luminal and basolateral membranes, we prepared freshly isolated
TAL cells by enzyme digestion and Ca free treatment of single TAL
segments. Membrane voltages m' cellular conductances g and single
channel currents (CAN experiments) were measured. The resting
membrane potential was —73 2 mV (N = 38). The mean cellular
conductance in SWC experiments was 8.6 0.9 nS (N = 38). A K
upward concentration step to 19 mmol/liter depolarized Vm by 32 1
mV (N = 44), g was increased by 14 2% (N = 28). Reduction of
extracellular C1 to 30 mmol/liter hyperpolarized Vr by —8 1 mV (N
= 34) and reduced g by 12 2% (N = 18). Addition of Ba I
mmollliter to the extracellular side depolarized Vm by 20 2 mY (N =
15). Furosemide 100 jimol/liter hyperpolarized Vm by —5 1 mV (N =
24). NH4 10 mmollliter depolarized by 21 3 mV (N = 22). In the
presence of NH4 a Cl-concentration step to 75 mmol/liter depolarized
by 10 1 mV (N = 4) (control —8 2 mY). The effect of furosemide
in the presence of ammonium was increased to —15 5 mV (N 4)
(control —5 mV). The depolarization by a K concentration upward
step to 7.5 mmol/liter was diminished to 2 1 mY (N = 3), (control 16
5 my). In 17 CAN experiments K channels with a conductance of
54 4 pS were identified. They had a high cell-attached open proba-
bility and showed inward rectification. Addition of NH4 to the bath
solution reduced the K channel open probability reversibly. The data
suggest that NH4 enters the cell via the Na2ClK cotransport
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system. Intracellular dissociation to NH3 + H and membrane perme-
ability for NH3 cause intracellular acidification. This leads to the
inhibition of pH dependent K channels and cell depolarization.
Properties of non-selective cation channels in apical membrane of
cultured proximal tubular cells. Karin Loffler, J.S. Schwegler, and S.
Silbernagi, Department of Physiology, University of Wurzburg,
Wurzburg, Germany. The established opossum kidney cell line (OK)
serves as a model system for ion and substrate transport in the renal
proximal tubule. Preliminary experiments revealed two pH-dependent
Nat-conductive channels with 22 pS and 146 pS single channel con-
ductance, located at the apical membrane. In the present study we
applied the patch clamp technique (excised inside-out configuration) to
determine the properties of the low-conductive channel. This cation-
channel is highly selective towards C1, but non-selective in regard to
monovalent cations (Na, K, Lit, Cs). It shows long open and
closed states, and its open probability increases at depolarizing mem-
brane potentials. This low-conductive channel is inactive in the cell-
attached mode but becomes active immediately after excision of the
patch. Within 60 to 90 seconds after this activation we mostly observed
a very quick "run-down" which cannot be prevented by varying
Ca-concentration (l0, 10—6, 0 mmol/liter) or by adding 1 mmol/liter
Mg and ATP. In case of an intracellular acidification, this non-
selective cation channel might support Na-reabsorption independently
of influx by co-transport with other substrates, such as glucose or amino
acids or of Na/Htexchange.
Specificity of the Na-2C1-K cotransport system towards diuretics in
rabbit macula densa cells. E. Schiatter, Z. Eberhard, and F.M. Bleich,
Markus Physiologisches institut, Universität Freiburg, Freiburg, Ger-
many. NaCI is taken up by Macula densa (MD) cells via Na-2C1-K
cotransport in the luminal membrane. Changes in cytosolic Cl alter
membrane voltages (Vm) in these cells. Reduction in luminal NaCl or
furosemide hyperpolarize Vm. Furosemide also blocks tubuloglomeru-
lar feedback. Effects of diuretics on membrane voltages (Ym) of MD
cells were examined. Glomerula with the thick ascending limb (TAL)
and the MD region were isolated, MD cells exposed by collagenase
treatment, and Vm measured with the slow whole-cell patch clamp
method. In 15 MD cells, Vm was —71 mY, which is higher than values
previously measured with microelectrodes, but corresponds to those of
TAL cells. An increase in extracellular K concentration from 3.6 to
18.6mmol/literdepolarizedYmfrom —73 2to —42 1 mV(N= 11).
Ba2 (1 mmollliter) depolarized Vm from —72 5 to —61 4 mV (N =
7). These data indicate the dominance of the K conductance also in
MD cells. The influence of various diuretics, active and inactive in
TAL, on Vm of MD cells was tested and IC50 values were determined:
IC50 for furosemide (N = 9) was 3 smol/liter, for piretanide (N = 11) 1
mol/liter and for torasemide (N = 8) 0.7 mol/liter. Muzolimin (N = 7)
and hydrochlorothiazide (N = 6), both inactive in TAL, were without
effect ( 100 mol/1iter). These IC50 values are almost identical to those
found for the cotransporter in TAL cells. The specificity of various
diuretics and identical concentration dependencies of Vm in MD cells
and NaCl transport in TAL cells indicate that both cells possess the
same Na-2Cl-K cotransporter responsible for NaCI uptake. These data
also explain that only loop diuretics of the furosemide type inhibit the
tubuloglomerular feedback mechanism.
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Regulation of renal Na+alanine cotransport by intracellular cations. J.
Hoyer, and A. Distler, Universitätsklinikum Steglitz, Berlin, and Max-
Planck-Institut für Biophysik, Frankfurt, Germany. Aim and methods:
Recently we studied the regulation of the Na-alanine cotransporter by
membrane potential. For further characterization of the cotransporter
mechanism, the effects of intracellular H, Na, and Ca on Na-
alanine cotransport kinetics were tested. Cotransport was investigated
in proximal convoluted tubule cells from rabbit kidney with the whole-
cell recording mode of the patch clamp technique. Results: Decreasing
intracellular pH from 7.2 (control, N = 5) to 6.4 decreased maximal
transport rate (I,,), with no effect on Km for L-alanine (N = 4).
Increasing [Na] from 0 (control) to 20 m led to an increase in KM and
Imax (N = 5). Increasing [Ca2] from 0.1 to 10 M had no effect on
cotransport.
Imax (p
—60
mV
A/pF)
0
mY
Km
—60
mV
m
0
mV
Control 0.89 0.54 6.8 7.5
pH 6.4 0.65a 036 8.6 9.1
20mM Na 1.12 0.69 l4.l 12.9a
a p < 0.05
Conclusions: Na-alanine cotransport is regulated by intracellular pH
and Nat Decrease of 'Max due to low intracellular pH presumably
represents an inhibition of the translocation step, whereas extracellular
pH does not affect the cotransport. Decrease of Km by intracellular Na
indicates an inhibition of the debinding of Na-ions from the cotrans-
porter in the presence of intracellular Na.
Resistance to phosphaturic effect of parathyroid hormone (PT}1):
Studies on isolated cells from renal tubules. A. Hoppe, M. Slaba, G.
Kucha, A. Rybczynska, Department of Clinical Biochemistry, Medical
Academy Gdansk, Gdansk, Poland. We have previously shown that
either respiratory alkalosis or short-term phosphate deprivation induces
resistance to phosphaturic effect of PTH in rats. This defect (a) is
localized exclusively in pars recta of proximal tubule, (b) lies beyond
the cAMP formation, and (c) might be removed by f3- and /32-adrenergic
antagonists. Those findings imply the difference in mechanism of PTH
action on phosphate transport between the convoluted (PCT) and
straight (PST) portions of proximal tubules. In search of peculiarity of
PTH action on PST, we developed the method of isolation of cells from
rat kidney enriched in (a) PCT and, (b) PST cells. Not less than 80% of
total (32p) uptake by cells represented Na-dependent uptake. There
were, however, differences in sensitivity of (32p) uptake to PTH,
dibutyryl (db)-cAMP and phosphodiesterase inhibitor, IBMX in PST
versus PCT cells.
db-
Cells origin
PTH cAMP IBMX
% of control Na-dependent (32p) uptake
PST 39a
PCT —27 —22 —21
In conclusion, the results indicate that: (a) PST cells seem to be more
sensitive to PTH, and (b) the majority of PTH-inhibitibie Na-dependent
P uptake by PST cells seem to be refractory to cAMP.
Probenecid inhibitable cortisol release—A system like the PAH-trans-
porter in the adrenal cortex (AC)? J. Steffgen, Heike Guse-Behling, B.
Herkommer, Monika Erhart-Bornstein, W.A. Scherbaum, HE. Franz,
and S.R. Bornstein, Abteilung Innere Medizin I u. IV., Universität
Ulm, Ulm, Germany. Recently, transport of cortisol but not of aldo-
sterone (Aid) or androstendione (And) by the renal PAH-transporter
was demonstrated. As the mechanism of cortisol release in the AC is
still unknown, we tested the AC for a similar system. ACTH stimulation
(b_b) in primary culture of bovine adrenocortical cells for 30 minutes
led to a five- to 10-fold increase of cortisol release. Ninety percent of
this effect could be inhibited by 5 msi probenecid (Prob), K = 0.1
0.02 mrvi Prob. ACTH stimulated release of Aid (And) increased three-
to fourfold (6—7) by Prob, indicating selective inhibition of cortisol
release without inhibition of the enzymatic pathway. Addition of 1 mM
PAH or tetrafluorosuccinate (TFS)) led to a further increase of ACTH
stimulated cortisol-release of 78% or 86%, indicating trans-stimulation
of a countertransport. Twenty-four hour incubation with 1 mrt TFS
reduced ACTH stimulated cortisol release by 35%, indicating cis-
inhibition by intracellular accumulated TFS. The results suggest the
existence of probenecid inhibitable cortisol countertransport.
Distribution of erythropoietin (EPO) producing cells in rat kidneys
during hypoxic hypoxia. K.-U. Eckardt, S.T. Koury, C.C. Tan, S.T.
Schuster, P.J. Raicliffe, B. Kaissling, and A. Kurtz, Department of
Physiology, University of Regensburg, Regensburg, Germany. To char-
acterize the control of renal EPO formation during hypoxic hypoxia we
have used in situ hybridization to determine the localization and
distribution of cells expressing the EPO gene in kidneys of rats exposed
to hypoxia of different severity and duration (7.5% 02 for 4, 8 and 32 hr;
9% 02 for 8 hr; 11.5% 02 for 8 hr). The number of cells containing EPO
mRNA on tissue sections was related to tissue concentrations of EPO
mRNA and to serum hormone levels. Under all conditions tested, EPO
mRNA was exclusively detected in peritubular cells that were predom-
inantly located in the cortical labyrinth. After four hours of severe
hypoxia (7.5% 02) approximately 170-fold more cells were found to
contain EPO mRNA than under normoxic conditions. Between four
and eight hours exposure to 7.5% 02 the number of EPO producing cells
did not change significantly, but the amount of EPO mRNA per cell
increased approximately threefold. Further continuation of hypoxia
resulted in down-regulation of EPO mRNA levels, which was mainly
due to a reduction in the number of cells containing EPO mRNA.
Comparison of graded degrees of hypoxia applied for eight hours
showed an inverse exponential relationship between oxygen tensions
and the number of EPO producing cells. This recruitment occurred
along a gradient from corticomedullary border to subcapsular tissue. In
view of previous studies, these findings indicate that the control of EPO
formation under anemic and hypoxic hypoxia is similar, since (i) the
renal cell type producing EPO appears to be identical, and (ii) recruit-
ment of cells expressing the EPO gene is a major determinant of EPO
production rate under both conditions.
Thyroid hormones stimulate the production of erythropoietin. H.
Pagel, J. Fandrey, and W. Jelkmann, Institutes of Physiology, Medical
University of Lubeck and University of Bonn, Germany. Clinical and
experimental studies have shown that thyroid hormones (T2/T3/T4)
influence erythropoiesis. It is assumed that they stimulate the synthesis
of erythropoietin (Epo). In the present study it was examined whether
thyroid hormones increase the production of Epo independently from
their calorigenic action. Methods: The study was performed under
hypoxic conditions (PO2 max. 35 mm Hg) in cultures of a human
hepatoma cell line (HepG2) and in the isolated perfused rat kidney
(IPRK). Results: The table summarizes the measurements of Epo
production:
T2 (10 T3 (lO_8 T4 (10
Control M) M) M)
NS: P > 0.05; a. P < 0.05 vs. control; means SD of 4 to 8
experiments.
Both in HepG2 cells and in the IPRK, T3 and T4 augmented the
hypoxia-induced Epo-production, whereas T2 had no effect. None of
a P < 0.05 vs. PCT values (paired Student t-test) HepG2
Epo after 24 hr
of incubation
U/g cell protein
IPRK
Epo after 3 hr
of perfusion
mUig kidney
226 33 263 40 407 65 346 17
NS a a
414 69 482 121 892 144 1073 366
NS a a
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the hormones increased the 02-consumption. Conclusion: T2, which
primarily acts via the mitochondrion, has no influence on Epo-produc-
tion. Without having an effect on the 02-consumption, both T3 and T4
directly stimulate the synthesis of Epo. We throw open to discussion
that T3 and T4 exhibit this effect via the nuclear pathway.
Cells from medullary thick ascending limb of Henle loop (MTAL) as a
source of adenosine (ADO). G. Kucha, A. Rybczynska, A. Hoppe, and
S. Angielski, with the technical assistance of G. Dzierzko, Department
of Clinical Biochemistry, Medical Academy, Gdansk, Poland. Previous
experiments from our laboratory suggest that adenosine (ADO) origi-
nating from mTAP might serve as signal for glomerulo-tubular feedback
phenomenon. To find a condition in which ADO might be produced, we
developed the method of isolation of cells from rat kidney enriched in
mTAL and proximal convoluted tubule (PCT) cells. During the sepa-
ration of mTAL cells, the ice-cold intracellular-like medium supple-
mented with 300 mH urea was used. In case of PCT cells the urea was
omitted. In present experiments, the cells were suspended in extracel-
lular-like medium: NaC1, 115; NaHCO3, 25; NaH2PO4, 2; KCI, 5;
CaCl2, I; MgSO4, 1; urea 300 mH; pH, 7.40 were incubated five minutes
at 37°C. Urea was omitted in the case of PCT cells. The cells were
incubated in anoxic (02, 0 mm Hg) and normoxic (02, 100 mm Hg)
conditions and ATP and ADO were measured luminometrically. In
anoxic PCT the ATP content decreased to 19% of normoxic values (P
<0.001), but no change was observed in mTAL cells. In contrast, ADO
increased by 47% (P < 0.001) of normoxic values only in anoxic mTAL
cells. This increase was abolished by furosemide (1 mM) or ouabain (1
mM). No effect of furosemide or ouabain was observed in PCT. We
conclude that: (a) ATP content in mTAL cells in far less sensitive to five
minutes anoxia than in PCT cells which might be ascribed to glycolysis
as source of ATP, and (b) the mTAL cells might be a source of
Na-transport dependent increase in ADO at low 02 tension.
Humoral control of renal medullary blood flow. N. Parekh, A.P. Zou,
Pinlan Li, and M. Steinhausen, I. Department of Physiology, Univer-
sity of Heidelberg, Heidelberg, Germany. Using newly developed
electrodes for measuring tissue blood flow, we investigated medullary
circulation in female Wistar rats. The effect of different endogenous and
exogenous vasoactive hormones on medullary blood flow was com-
pared with that in the cortex. Converting enzyme inhibition with
qinapril (40 gJkg/min) had no effect on the medullary blood flow, but it
increased cortical flow (20 2%). Prostaglandin inhibition by indo-
methacin (40 g/kg/min) decreased only the medullary blood flow (—24
4% in control rats and —16 4% in quinapril treated rats). We also
examined effects of iv. administration of angiotensin H (Ang H),
norepinephrine (NE), arginine vasopressin (AVP) and nitroarginine
methyl ester (NAME, an inhibitor of NO-synthase). Each of them was
given at a dose sufficient to reduce cortical blood flow by about 25%
within 10 minutes. Under control conditions Ang II and NE reduced
medullary blood flow only transiently, whereas AVP and NAME
caused sustained reductions. After indomethacin treatment each con-
strictor caused an additional sustained reduction in medullary flow
which was comparable to that in the cortex. Reductions in medullary
flow before and after INDO were: Ang II, 2 2% and 44 6%; NE, 4
2% and 34 4%; AVP, 25 4% and 29 5%; and NAME, 38 7%
and 39 5%. Our data show that renal medulla has high basal levels of
vasodilator prostaglandins and their production can be further stimu-
lated by Ang II and NE. Prostaglandins mediated vasodilation protects
the renal medulla against the constrictor effect elicited by Ang II or NE
but not against that by AVP or NAME.
Influence of the renin-angiotensin system (RAS) on renal functional
reserve (RFR). P. Heering, Danja Wyes, J. Plum, B. Grabensee, and H.
Heine, University, Düsseldorf, Germany. To investigate the RFR we
measured C1,, and CPAH during infusion with NaCI and amino acids
(AA) in controls (group I, N = 8), renal graft recipients (group 2, N =
8) and patients after nephrectomy (group 3, N = 8). During infusion we
determined plasma renin activity (PRA), aldosterone (ALD), ANP and
in group I the RFR during acute application of captopril. During AA
application C1,, increased in controls from 96.5 3.3 mI/mm to 111.9
4.4 mI/mm (P < 0.05), and CPAH only slightly from 577 28.7 to 618.9
38 mI/mm (NS). In group 2 C1,, increased marginally from 78.4 5.8
to 84.7 6.5 mI/mm (NS). In group 3 C1, did not increase (84.5 6
mI/mm), but CPAH did from 345.7 26.3 to 409 24.1 mI/mm (P <
0.05). PRA and ALD remained unchanged. In group 1 ANP (80.5 9.3
pg/mi) did not increase during AA infusion compared to NaCI. During
the application of AA and 25 mg captopril C1,, increased to 125.0 16.4
mI/mm (P < 0.01), CPAH marginally to 595 77 mI/mm (NS). RFR was
diminished in patients with reduced renal mass. The increase in GFR
was not mediated by the RAS or by ANP. Acute blockade of RAS did
not inhibit AA mediated hyperfiltration.
Role of endothelin and endothefium-derived relaxing factor in control
of basal vascular tone in rat kidneys. J. Hoffend, E. Gulbins, A.P. Zou,
A. Cavarape, and M. Steinhausen, I. Institute of Physiology, Univer-
sity of Heidelberg, Heidelberg, Germany. In order to investigate to
which degree renal vascular tone is controlled by endothelin (ET) and
endothelium-derived relaxing factor (EDRF) under basal conditions, we
tested the effects of anti-ET-l/3-antibodies (a-ET-l/3) and L-nitro-
arginine methyl ester (L-NAME) on the split hydronephrotic rat kid-
ney, an in vivo model of the renal microcirculation. A 25 minute i.v.
infusion of a-ET-l/3 (4.8 . lO mol kg' . min') induced a time-
dependent vasodilation of arcuate (+ 16.5%) and interlobular arteries
(+ 18.6%) as well as an increase of glomerular blood flow (GBF) by 32%
without change in systemic blood pressure. Inhibition of EDRF syn-
thesis by L-NAME produced a marked vasoconstriction of arcuate
(—17.1%) and interlobular (—6.6%) arteries and of efferent (—20.1%)
arterioles and a decrease of GBF by 43%. Infusion of both a-ET-1/3 and
L-NAME induced efferent vasoconstriction by 19.5%, whereas pre-
glomerular vessel diameters remained unchanged. The specifity of
a-ET-1/3 effects was confirmed by simultaneous iv. application of
a-ET-l/3 and ET-1 (160 ng) which produced no significant vasëular
effects. Injection of ET- 1 (160 ng iv.) alone constricted arcuate arteries.
Our results demonstrate a physiological control of basal vascular tone
in larger preglomerular arterioles by ET and EDRF. Basal efferent
arteriolar tone is predominantly controlled by EDRF.
Endothelin (ET)-1 receptor characteristics in porcine inner medullary
collecting duct (IMCD) cells. 1. Migas, A. Backer, H. Michel, H.
Meyer-Lehnert, and H.J. Kramer, Medical Policlinic, Department of
InternalMedicine, University of Bonn, Bonn, Germany. In the present
study we investigated in porcine kidney ET receptors which are present
in papillary tissue, but not in glomeruli. We isolated IMCD cells from
papillary tissue of 24 kidneys by Percoll density gradient centrifugation
after enzymatic and hypotonic treatment. Studies were performed in
fresh cell suspensions and in cultured cells. Optimum binding of ET-1
was obtained with IMCD cells, 30 sg protein, incubated in PSS with
BSA, N-acetyl-DL-methionmne and aprotinin for 120 minutes at 37°C
and pH 7.0. Total and unspecific binding amounted to 16.3% and 3.9%,
respectively. LIGAND analysis showed an average Bm,,x of 265 29
fmol/mg prot and Kd of 77 28 pM. ET-1 binding was stable and
internalization cannot be excluded. ET-1, l0— to l0 M, dose-
dependently raised Ca24 four- to tenfold, respectively, from a basal
level of 50 nmoi. This rise was modestly attenuated by TMB-8, an
inhibitor of Ca2°1 release, and by verapamil, respectively. ET-1 sup-
pressed basal and significantly attenuated AVP-induced cAMP genera-
tion. Thus, porcine IMCD cells possess high affinity ET-l receptors.
ET-1 raises Ca21 through release from intracellular stores, activation of
L-type Ca channels and, probably to a larger extent, through unselec-
tive cation channels. ET-l suppresses AVP-induced cAMP synthesis,
suggesting a role in renal regulation of body fluid balance.
Endothelin-dependent stimulation of nuclear proteinkinase C in iso-
lated renal cell nuclei. B. Hoccher, H. Abou-Rebyeh, R. Zart, F. Laube,
F. Korber, Ch. Bauer, A. Distler, and P. Gross, Department of
Nephrology, Klinikum Steglitz, and Institute of Molecular Biology and
Biochemistry, Free University of Berlin, Berlin, Germany. Endothelin-l(Et-l) acts via cell membrane-bound receptors (Et-RA and Et-RB).
Recently, there has been evidence of intracellular binding sites of
peptide hormones. In a recent study, Et-1 receptors could be charac-
terized in liver cell nuclei from rats. Based on these findings, we tried to
demonstrate Et-l receptors also in isolated renal cell nuclei. Renal cell
nuclei were isolated by density gradient centrifugation. The purity of
the nuclei was assessed with electron microscopy and marker enzymes
(5 '-nucleotidase, succinate-INT-reductase, Glc-6-phosphatase). Scat-
chard analysis of isolated renal cell nuclei from rats demonstrated a
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single class of high-affinity Et-l receptors. Receptor density (Bmax: 19
fmol/liter) and binding constant (Kd: 0.21 nmollliter) were comparable
to those of endothelin receptors in liver cell nuclei. Binding of Et-l to
nuclear receptors caused a significant time- and dose-dependent acti-
vation of a nuclear-, calcium- and phospholipid-dependent proteinki-
nase, with a maximum after three to five minutes of incubation.
Stimulation of proteinkinases is demonstratable already at concentra-
tions of 10.2312 mol/liter of Et-1. Conclusions: A single class of high-
affinity Et-l receptors are demonstratable also in renal cell nuclei.
Binding of Et-l to these receptors results in activation of nuclear
proteinkinases already at very low concentrations of Et- 1. In vivo
binding to nuclear receptors via (the previously shown) internalization
of Et-1 is conceivable. A process of this kind might be relevant for the
known mitogenic effect in renal cells.
Role of the vascular endothelium in the pressure control of renin
secretion. H. Scholz, and A. Kurtz, Physiologisches Institut I, Univer-
sitat Regensburg, Regensburg, Germany. Renin secretion rates from
the kidneys are negatively correlated with the renal artery pressure.
The existence of a vascular "renal baroreceptor" for the pressure
control of renin release has therefore been hypothesized. The renin-
producing juxtaglomerular (JG) cells in the afferent arterioles differen-
tiate from vascular smooth muscle cells (VSMC). In our study we have
therefore examined a possible role of the vascular endothelium, in
particular of the endothelium-derived relaxing factor in the pressure
control of renin secretion. To this end isolated rat kidneys were
perfused in a recycling system with a synthetic medium containing 6
g/dl of bovine albumin and a 10% fraction of human erythrocytes.
Acetylcholine (ACH), a stimulus for EDRF synthesis from the amino-
acid L-arginine, caused a dose-dependent increase of basal flow and
renin secretion rates at a perfusion pressure of 100 mm Hg. Those
effects of ACH were markedly reduced in the presence of nitro
L-arginine, an inhibitor of EDRF formation. After addition of 1 mM
L-arginine the ACH induced vasodilation and stimulation of renin
release were partially reversible. Sodiumnitroprusside (SNP), an
EDRF-analogue, also increased renal flow and renin release to a similar
extent as ACH did. Decreasing the renal artery pressure from 100 to 40
mm Hg resulted in an increase of renin secretion rates from 3.0 0.5 to
maximally 79 12 (ng Ang I x li) x min x g' (X SEM, N = 10)
under control conditions. During inhibition of EDRF synthesis, renin
secretion at a pefusion pressure of 40 mm Hg was significantly de-
creased to maximal values of 16 3 (ng Ang I x h) x min X g'
and this effect was reversible with 1 mrvi L-arginine. Lowering of the
perfusion pressure to 40 mm Hg during simultaneous infusion of nitro
L-arginine and SNP resulted in renin secretion rates of 205 20 (ng Ang
I x h') x min x g'. Taken together, our findings suggest that
EDRF stimulates renin secretion from isolated perfused rat kidneys.
EDRF apears to account for the rise in renin release produced by a
decrease of the renal artery pressure.
Hypersensitivity to nitric oxide of glomeruli from dexamethasone-
treated rats. Barbara Lewko, J. Stepinski, and S. Angielski, Depart-
ment of Clinical Biochemistry, Medical Academy Gdansk, Gdansk,
Poland. Recent data suggest that dexamethasone may modify synthesis
and function of main vasodilatory agents, that is atrial natriuretic factor
(ANF) and EDRF (NO). Our aim was to investigate function of
glomeruli from the kidneys of the rats exposed for two days to
dexamethasone (Dex), deoxycorticosterone (DOCA, both I mg i.m./
day) or saline as a control (Co). Glomeruli were isolated by sieving
technique and subsequently incubated in the presence of sodium
nitroprusside (NPS) or ANF and production of cGMP was measured. In
the Co and DOCA groups increase in cGMP production was very slight
at NPS concentration of lO mol/liter. Maximal effect of NPS has been
observed at 5 x lO mol/liter (22.7 pmol cGMP/mg prot. vs. 5.8
pmol/cGMP/mg prot. in unstimulated glomeruli). Glomeruli isolated
from Dex treated rats respond to as low concentrations of NPS as 10—8
mol/liter (7.4 pmol cGMP/mg prot. vs. 3.0 pmol cGMP/mg prot. in
unstimulated glomeruli). Production of cGMP increases in this group up
to 36.2 pmol/mg prot. The O5 value for NPS estimated for the cGMP
production was significantly lower in the Dcx group (2 X l0— mol/liter)
than in the Co group (1.2 x iO mol/liter). No difference in ANF
activity between Dex and Co groups has been observed. Our results
suggest that glucocorticoids sensitize soluble guanylyl cyclase system
leading in consequence to dilation of the glomeruli of the rats.
Distribution of nitric oxide synthase (NOS) in the kidney. S. Bach-
mann, P. Mundel, and W. Kriz, Department of Anatomy and Cell
Biology 1, University of Heidelberg, Heidelberg, Germany. Nitric
oxide (NO), a signal molecule in the vasculature and nervous systems,
is generated from L-arginine by the constitutive type I NOS. We
investigated the distribution of NOS in cryostat sections of the kidney
of various species (rat, mouse, rabbit, Guinea pig) by means of three
distinct detection protocols: (a) immunohistochemically using a poly-
clonal antiserum against brain type I NOS, (b) histochemically using the
nicotinamide dinucleotide phosphate (NADPH) diaphorase technique,(c) at the mRNA level by in situ hybridization using a digoxigenin-
labeled NOS riboprobe. To check which of the diaphorase-positive
structures contained NOS and vice versa, protocols (a) and (b) were
applied to the same sections for double labeling. The strongest label was
present in the macula densa epithelium of the juxtaglomerular apparatus
as revealed by protocols (a) through (c). Combined application of
protocols (a) and (b) labeled throughout the same cells. Strikingly,
NOS-positive cells were frequently seen to exceed the morphologically
defined macula densa forming contacts to adjacent tubular and vascular
structures. Double labeling using protocol (b) and an antibody against
Tamm Horsfall protein (THP) showed that NOS positive cells were
THP-negative, whereas adjacent distal tubular cells were THP-labeled.
Double labeling using protocols (a) or (b) and an antibody against renin
revealed intimate contacts between distal tubular NOS-positive cells
and juxtaglomerular granular cells, especially when renin storage was
stimulated by volume depletion. Vascular NOS was detected in cortical
and medullary vessels using protocols (a) and (b); endothelial staining
was strong, whereas staining of the vascular media of the renal arteries
was weak. The glomerular efferent arteriole revealed strikingly intense
NOS-labeling both at the initial intraglomerular segment and outside the
glomerulus. Nerves accompanying cortical blood vessels contained a
small subpopulation of NOS-positive fibers. The results indicate a
prominent role for NOS in the kidney; apart from more general vascular
effects, NO might be involved in the regulation of glomerular hemody-
namics.
Proximal tubular renin-angiotensin system (RAS) in rat and mouse
kidney: Detection at the mRNA and protein level. J.B. Fiebach, and S.
Bachmann, Department of Anatomy and Cell Biology 1, University of
Heidelberg, Heidelberg, Germany. The kidney contains the entire set
of components of the RAS, and is therefore—in addition to its crucial
function in the endocrine RAS—to be classified among the organs and
tissues possessing a locally active RAS. Intrarenally generated angio-
tensin II (Ang II) exerts substantial effects on renal hemodynamics and
tubular reabsorptive function. We have localized mRNA and transla-
tion products of renal RAS components by in situ hybridization
histochemistry (ISH) and immunocytochemistry. Apart from the gb-
merular and juxtaglomerular RAS, the proximal tubule (PT) is the only
site with an expression of RAS components. Immunoreactive renin
detected in the apical cytoplasm of PT cells is probably not locally
generated but is rather derived from unspecific luminal uptake. Renin
mRNA is not detectable in rat PT as revealed by ISH, whereas in the
mouse a few scattered PT cells may express renin mRNA. Immunore-
active renin substrate, angiotensinogen (AOGEN) is present in the
convoluted part (PCT) but not in the straight part (PST) of the PT. In
contrast, ISH reveals that AOGEN mRNA is localized mostly to the
PST. Immunoreactive angiotensin converting enzyme (ACE) is local-
ized along the brush border membrane along the entire PT with highest
labeling density in the PST, whereas ACE mRNA, as shown by ISH in
the mouse kidney, is detectable only in the PST. These results indicate
a prominent synthesis of the local renal RAS in the straight part of the
proximal tubule. In terms of local Ang II action in the PT, a discrepancy
between the location of Ang Il-receptors mostly in the early PCT and an
RAS expression localized only further downstream, that is in the PST,
is obvious.
Potassium-channels and atrial natriuretic factor modulate constrictor
responses to angiotensin II and adenosine in isolated glomeruli. S.
Angielski, and M. Szczepañska-Konkel, Department of Clinical Bio-
chemistry, Medical Academy, Gda,isk, Poland. Atrial natriuretic factor
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(ANF)-induced glomerular hyperfiltration is blunted in sodium-de-
prived compared to normal rats. Similarly blunted hyperfiltration and
reduced natriuretic response to ANF have been reported in low-sodium
diet in humans. Moreover, isolated perfused kidney from salt-sensitive
and salt resistant Dahi rats maintained on a low-sodium intake has
previously been reported to remain refractory to ANF. In response to
ANF, urinary excretion of cyclic-GMP and its accumulation were
decreased in isolated glomeruli in low-sodium in comparison with
normal-sodium rats. In the present study, to elucidate the cellular
mechanism of this refractoriness, we investigated the effect of cr0-
macaIim, glibenclamid and ANF in Ang II or adenosine-induced gb-
merular capillary vasoconstriction using 3H-inulin to measure intracap-
illary volume of isolated glomerubi. We found that ANF (1 M)
completely reversed Ang 11(100 nM) precontracted glomeruli in normal-
sodium rats. However, ANF alone was ineffective, whereas both ANF
and cromakalim given together inhibited Ang lI-induced contraction of
glomeruli isolated from low-sodium rats. Glibenclamid (10 nM) com-
pletely abolished the relaxing effect of ANF (1 LM) on the Ang
Il-induced gbomeruli contraction in normal and in low-sodium rats.
Chloradenosine (1 /SM) potentiated Ang 11(10 nM) glomeruli contraction
obtained from normal and low-sodium rats. The potentiation was more
accentuated in glomeruli of low than in normal-sodium rats. These
findings indicate that ANF refractoriness in vivo is expressed also by in
vitro preparation of glomeruli isolated from low-sodium rats. Our
findings provide evidence for a control function of the ATP-dependent
potassium channels in glomeruli dynamics. Moreover, this finding
suggests that Ang II and adenosine hypersensitive contraction and ANF
refractoriness of glomeruli in low-sodium rats might be due to reversible
blockade of ATP-dependent potassium channels.
Interaction of cell volume, Ca and pH regulation in RAS oncogene
expressing NIH 3T3 fibroblasts stimulated with bradykinin. M. Ritter, E.
Wöll, D. Haussinger, and F. Lang, Institute of Physiology, University
of Innsbruck, and Department of internal Medicine, University of
Freiburg, Germany. Enhanced cell proliferation underlies a number of
pathophysiological conditions, including glomerulonephritis and inter-
stitial fibrosis. A model for the study of cell proliferation is RAS
oncogene expressing cells. Previous studies demonstrated that the
expression of RAS oncogene in NIH 3T3 fibroblasts causes marked
alterations of ion transport across the cell membrane, leading to agonist
(bradykinin) induced oscillations of intracellular calcium activity (Ca1),
increase of intracellular pH (pH) and a shift of the set point for cell
volume regulation towards greater volumes. These phenomena are
prerequisites for the initiation of cell proliferation. The present study
has been performed to test for the interaction of the ion transport
systems under the influence of bradykinin. Bradykinin leads to cellular
alkalinization, an effect inhibited by either 100 mol/liter dimethyl-
amiloride or 10 smol/liter HOE 694, a novel inhibitor of Na/H
exchange. Despite the activation of the Na/H exchanger, which
tends to swell cells, bradykinin leads to marked cell shrinkage. Cell
shrinkage leads in turn to cellular alkalosis by activation of Na41H
exciange. Prevention of cell shrinkage by simultaneous reduction of
extracellular osmolarity almost abolishes the bradykinin induced cellu-
lar alkalinization. Thus, the bradykinin induced cell shrinkage partici-
pates in the activation of the Na/H exchanger. Furthermore, the
bradykinin induced cell shrinkage is one prerequisite for the bradykinin
induced Ca1 oscillations, which cease upon reduction of extracellular
osmolarity. In conclusion, bradykinin decreases the cell volume of RAS
oncogene expressing cells, an effect contributing to activation of NafH
exchange, intracellular alkalinization and altered regulation of Ca1.
Mechanosensitive calcium channels in mesangial cells: Myogenic re-
sponse in glomeruli? R. Nobiling, and M. Pajireiter, I. Physiologisches
Institut, Heidelberg, Germany. Contractile properties of glomerular
mesangial cells (MC) have often been described, at least in cultured
cells. Although their contractility in situ is still under debate, there is a
certain agreement about morphological and functional similarity to
vascular smooth muscle cells in resistance vessels. We cultivated
mesangial cells on elastic backings (1st to 6th passage) and applied short
(about Is), transient stretches of 5 to 20% of the length. We measured
[Ca2]1, using the trapped fluorescent indicator fura 2. [Ca2]1 in
individual cells was continuously monitored except during the stretch.
The observed transient rises of [Ca2]1 had comparable shape and
kinetics as those that are evoked by humoral stimuli such as angiotensin
II. In contrast to drugs, Ca2-free superfusion completely abolished the
stretch-induced {Ca2]1 transients. Therefore, a direct Ca2 influx
seems more likely than a contribution from receptor-operated messen-
ger systems with subsequent Ca2 release from intracellular stores. A
characterization of the calcium channel with our method is hampered
by the extreme light sensitivity of virtually all organic Ca antagonists.
However, the measurements clearly show the ability for a stretch-
induced activation of the mesangium that points to the possibility of a
myogenic component in the glomerular regulation.
Effect of extracellular ATP on contraction, cytosolic calcium activity
[Ca4]1, membrane voltage (Vm) and ion currents of rat mesangial cells
(MC) in primary culture. H. Pavenstädt, J. Gloy, J. Leipziger, J.
Pfeilschifter, P. Schollmeyer, andR. Greger, Departments of Medicine
and Physiology, University of Freiburg, Freiburg, Germany, and
Biozentrum Base!, Base!, Switzerland. The present study was per-
formed to investigate cellular mechanisms of the vasoactive agent ATP
in MC. [Ca]1 was determined with the fura-2 technique with a single
cell photon counter. Vm and ion currents were measured with the
nystatin patch clamp technique. Addition of ATP (l0- M, N 9) to
MC resulted in a cell contraction and in a dose dependent increase of
[Cai; (EC50: 5 x 10 M, N = 6). The ATP induced [Ca]1 increase
showed a biphasic nature with an initial transient peak followed by a
sustained plateau of increased [Ca]1. In a calcium-free extracelbular
solution, the peak was still present, whereas the plateau was inhibited.
Verapamil (l0 M, N = 6) was not abbe to inhibit the [Ca]1 increase
induced by ATP. ATP (l0- M, N = 25) depolarized Vm (—49 I mV)
transiently by 15 4 mY. In parallel, an increase of the inward- and
outward current by 21 4% and 17 4% was observed, respectively.
In a buffer with a reduced extracellular chloride concentration (from 145
to 30 mM) ATP caused an increased depolarization of Vm to —4 4
mV. 2-methylthio-ATP depolarized Vm to the same extent as ATP,
whereas alpha,beta-methylene-ATP had no effect on Vm. Furthermore,
A 23187 (10_6 M, N = 8) depolarized Vm and caused an increase of the
inward current. The data indicate that extracellular ATP is able to
contract MC and to increase [Ca]1 by releasing calcium from intra-
cellular stores and recruiting it from the extracellular space. In addition,
ATP activated a chloride conductance via a P2w-receptor in MC. The
regulation of the [Ca}1 seems to play an important role in the
activation of the chloride conductance.
The autocrine growth regulation of human gbomerular mesangial cells
(HMC) and the role of interleukin-6. H.H. Radeke, A. Francki, Juliane
von der Ohe, and K. Resch, Institute Molekular-Pharmakologie,
Medizinische Hochschule, Hannover, Germany. Independent from the
initiating events, many forms of glomerulonephritis (GN) are charac-
terized by HMC proliferation and matrix deposition, finally leading to
loss of glomerular function. Recent studies in rat models confirmed in
vivo that PDGF (platelet derived growth factor) represents the key
stimulus for MC growth, while in earlier investigations interleukin-1
(IL-lj3) and IL-6 have been favored. The initial experiments of our in
vitro study showed that both growth arrested rat MC and HMC (72 hrs
serum-free culture) could be stimulated to proliferate by MC superna-
tants (SN) in an autocrine fashion. The supernatants used were col-
lected from serum-free cultured MC and concentrated by CentriprepR
(cut-off size: 10 kDa) centrifugation 100-fold. Serial studies with HMC
demonstrated that the autocrine proliferation was time- (12 to 72 hrs)
and concentration-dependent (applied 100-fold SN: 0.1 to 10%). This
effect was detectable with autologous SN and also with SN's of HMC
prepared from five separate donors. Moreover, IL-1J3 stimulation of
HMC prior to collection of SN time and concentration dependently
enhanced the proliferation of HMC responding to the concentrate. In
order to determine which factor produced by HMC might be responsi-
ble for the autocrine growth induction, we first investigated the time-
and dose-dependent effects of the following recombinant cytokines:
IL-113, IL-6, PDGF (isoforms AA, AB, BB; donated by J. Hoppe), EGF
(epidermal growth factor), TGFI3 (transforming growth factor-/3) and
bFGF (basic fibroblast growth factor). As previously shown both
interleukins had no effect on proliferation. TGFP (I ng/ml) reduced
basal [3HJ-thymidine incorporation by 50% after 72 hours. The remain-
ing proteins induced HMC proliferation (up to 9-fold) with the following
rank order: PDGF-BB > PDGF-AB > bFGF > PDGF-AA > EGF.
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Subsequently, employing neutralizing antibodies (L.A. Aarden: c-IL-6;
C.-H. Heldin: a-PDGF; J. Floge: a-bFGF; NIBSC: a-IL-la//3) we
showed, that PDGF induced proliferation was inhibited by a-PDGF and
a-IL-6. Interestingly, bFGF induced growth was neutralized by
a-bFGF, a-PDGF and a-IL-6. We are currently investigating the effects
of these antibodies on autocrine HMC proliferation. These studies
might contribute to the understanding of the network involved in
mesangioproliferative GN.
Differential effect of arginine vasopressin (AVP) and angiotensin II
(Ang II) on proliferation and expression of the immediate early genes
c-los, c-jun and Egr-1 in cultured mesangial cells (MCs). E. Schulze-
Lohoff, M. Köhler, H. Fees, N. Reindl, and R.B. Sterzel, Med. Klinik
JV, University of Erlangen-Nurnberg, Germany. AVP and Ang II
induce similar signaling events in cultured mesangial cells (MCs), such
as increase of intracellular calcium or activation of phospholipase C and
A2. By contrast, these peptides show different mitogenic effects on
cultured rat MCs: AVP (l0— M) strongly stimulates 3H-TdR uptake
3.7-fold at 48 hours and increases MC count by 42% (P < 0.05), while
Ang II is not mitogenic. We tested the hypothesis that activation
pathways of AVP and Ang II diverge at the level of growth associated
genes, in particular the immediate early genes (lEGs), c-fos, c-jun and
Erg-I. Receptor activity for AVP and Ang II of cultured rat MCs was
controlled by the ability of both peptides to induce PGE2, protein
synthesis and ornithine decarboxylase. Furthermore, a receptor binding
assay for Ang II also confirmed presence of Ang II receptors. mRNA
levels for c-fos, c-jun and Egr-l were determined by Northern blot
analysis. Upon stimulation of resting MCs with AVP (10—l0— M), we
observed maximal expression of the LEGs at 0.5 to 1 hour, The relative
increases of the various lEGs were: c-fos 15-fold, c-jun 12-fold, Egr-l
6-fold. Under these conditions, Ang II (l0—l0— M) was not able to
induce any of these genes. Our results demonstrate that AVP, but not
Ang II, is a strong inducer of the lEGs c-fos, c-jun and Egr-l in cultured
MCs. We conclude that signaling pathways for AVP and Ang II in MCs
diverge proximal to the expression of lEGs. The different expression
pattern of these genes may explain the different mitogenic response of
MCs to AVP and Ang II.
Immunocharacterization of protein kinase C isoenzymes in rat kidney
glomeruli, and cultured glomerular epithelial and mesanglal cells. Andrea
Huwiler, E. Schuize-Lohoff, D. Fabbro, andf. Pfeilschjfler, Biocenter,
University of Base!, Department of Pharmacology, Basel, Switzerland,
Ciba-Geigy Ltd., Basel, Switzerland, Department of Internal Medicine
IV, University of Erlangen-Nurnberg, Erlangen, Germany. Protein
kinase C (PKC) is a key enzyme in the signaling pathways that regulate
glomerular functions. To understand the role of PKC in renal homeosta-
sis, the expression and localization of PKC isoenzymes have been
investigated. The isoforms of PKC present in rat kidney glomeruli,
primary cultures and cell lines of glomerular epithelial and mesangial
cells, were identified by immunoblot analysis with isotype-specific
antibodies. Glomeruli were found to express five PKC isoenzymes,
PKC-a, -13, -6, -E and -. No PKC-y isoenzyme was detected. Out-
growth from isolated glomeruli after five days in culture, considered to
be mainly epithelial cells, displayed strong imniunoreactivity for
PKC-a, -6, -E and - isoenzymes. No PKC-/3 and -y isofonns were
detectable. Outgrowth from isolated glomeruli after 21 days of culture,
considered to be mainly mesangial cells, similarly expressed PKC-a, -.5,
-E and -isotypes. Moreover, we characterized PKC isoenzyme content
of stable cell lines of rat kidney glomerular cells. Here we report that
cloned epitheial and mesangial cell lines expressed PKC-a, -6, - and-'
isoforms. Subcellular distribution of PKC isotypes displayed clear
differences, depending on the cell type and the isoenzyme examined.
Phorbol l2-myristate 13-acetate stimulation of PKC caused down-
regulation of PKC-a, -S and -E isoenzymes in epithelial and mesangial
cells. In contrast, PKC- is resistant to phorbol ester-induced down-
regulation in all cell types examined. Further work is required to
determine the role of these PKC isoenzymes in regulating glomerular
blood flow and filtration in response to hormones and cytokines.
The release of gelatinase (collagenase type IV) from glomerular mesan-
gial cells and its extracellular activation by plasmin. M. Schonermark,
Ch. Wagner, M. Klostermann, M. Kramer, and G.M. Hänsch, Institut
für Immunologie der Universitdt Heidelberg, Heidelberg, Germany.
The release of intrinsic proteolytic enzymes seems to be one of the most
important mechanisms in glomerular damage. GMC produce type IV
collagenase, which can be detected in zymographic assays as a 72kD
and 92kD digestion band. The release of the enzyme can be stimulated
by inflammatory mediators, such as TGF-13 or C5b-9. The released
collagenases, however, are inactive. '4C-labeled collagen type IV is not
cleaved. How the enzymes are activated physiologically is not yet
clear. We investigated whether the ubiquituous protease plasmin was
able to activate the produced collagenase. Incubation of GMC-super-
natants with plasmin led to a reduction of the MW of the collagenases,
detected in the zymographic assay. In parallel, the activated superna-
tant was able to cleave the radioactive collagen. To test whether GMC
could generate active plasmin on their surface-only surface-bound
plasmin is not inactivated by plasma-antiplasmins, GMC were stimu-
lated with C5b-9 and TGF-13 and plasminogen was added. The cells
produced the plasminogen activator uPA and were able to convert the
plasminogen to active plasmin. Thus, GMC possess a tightly controlled
proteolytic tool, which may be important in physiologic glomerular
matrix homeostasis or pathologic glomerular damage, respectively.
Induction of manganese superoxide dismutase (MnSOD) mRNA levels
by phorbol ester: Implications for mechanism of interleukin I (IL-I)-
mediated expression of MnSOD. W. Gwinner, H.S. Nick, and C.C.
Tisher, Division of Nephrology, Medical School Hannover, Germany,
Division of Nephrology, and Department of Biochemistry and Molec-
ular Biology, University of Florida, Gainesville, Florida, USA. Super-
oxide dismutases are antioxidant enzymes that detoxify free oxygen
radicals. We have observed a dramatic induction of steady state mRNA
levels for the mitochondrial localized MnSOD in cultured glomerular
epithelial cells (GEC) by IL-I and bacterial lipopolysaccharide (LPS),
thus suggesting an important protective role for MnSOD in radical-
mediated injury in glomerular inflammation. Induced MnSOD mRNA
levels were found to be dependent on de novo transcription and
independent of new protein synthesis. However, the intracellular
signaling mechanism by which IL-i and LPS induce MnSOD mRNA
levels is not yet understood. To evaluate the involvement of a protein
kinase C (PKC)-dependent mechanism for this induction, primary
cultures of rat GEC were treated with a PKC activator, 12-0-tetrade-
canoylphorbol 13-acetate (TPA). TPA treatment resulted in a dose- and
time-dependent induction of MnSOD mRNA levels, At the induction of
MnSOD mRNA by IL-I and LPS the induction by TPA required de
novo transcription but not de novo protein synthesis. These findings are
compatible with a PKC-mediated mechanism for the MnSOD mRNA
induction observed with IL-l and LPS. To further evaluate this
hypothesis the PKC activity in the GEC was down-regulated and the
cells were then treated with IL-l and LPS. PKC down-regulation did
not inhibit the IL-l- and LPS-mediated MnSOD mRNA induction,
indicating that this induction is not dependent on PKC activation.
Conclusion: MnSOD mRNA levels in GEC can be induced by at least
two different intracellular signaling pathways: (1) a TPA-dependent
mechanism, presumably PKC activation, and (2) an, as of yet, unknown
PKC-independent signaling pathway that is activated by IL-i and LPS.
Characteristics of rat papillary interstitial cells in primary culture.
C.T. Grupp, J.F. Silomon, D.I. Cohen, and H.E. Franz, Sektion
Nephrologie der Universität Ulm, Ulm, Germany, Department of
Physiology, Cornell University, New York, USA. Interstitial cells (IC)
of the kidney are regarded as important target and production sites of
various hormones in the papilla; the lipid loaded cells (IC type 1
according to Bohmann) are especially considered to play an important
role with respect to this. For further characterization we developed an
isolation technique to enrich these cells in high purity in primary culture
(PC). Contaminations with collecting duct cells (CD, lectin DBA
positive) and cells of the thin loop of Henle (tLH, AB Anti-I pos.) were
<3% and <20%, respectively; few endothelial cells (AB Factor VIII
pos.) were detectable under the chosen conditions (DMEM/Haml2; 10
to 20% FCS) only during the first days of culture. PC of the isolated IC
were examined with regard to their cytoskeleton. As expected, they
were negative for cytokeratins in contrast to CD and tLH. Vimentin
was not a useful marker for discrimination, because in PC it was
expressed by all cells. Exclusively, cells of the IC-fraction were stained
by ABs against alpha actin and desmin, whereas frozen sections of rat
papilla were negative for these markers. Double-staining with a lipid
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dye (Sudan III) demonstrated that the lipid loaded cells only weakly
expressed these markers. Alpha-actin positive cells contained small or
no lipid droplets. This cell type was the fastest growing in culture. After
several passages almost all cells were alpha-actin positive. It remains to
be determined whether these cells are a form of type I IC or pericytes.
Tubular epithelial cells in culture present superantigens and stimulate
T-cell proliferation. Antje Karau, G. Maria Hansch, and Margarita
Schôls, Institut für Immunologie der Universität Heidelberg, Heidel-
berg, Germany. Human tubular epithelial cells in culture (TEC) express
class II antigens when stimulated with y interferon. To test whether
TEC may also present antigens, we used staphylococcus enterotoxins
(SE) as superantigens. SE are bound by class II antigens and are
recognized by a constant domain of the T-cell receptor for antigen.
Class II positive TEC were incubated with SE and isolated peripheral
T-cells or alternatively with cloned T-cells. After 48 to 72 hours,
proliferation of T-cells was seen. Various SEs were used; SED was
most efficient, while SEA or SEE stimulated proliferation to a lesser
degree. TEC, which did not express class II antigens did not induce
proliferation. TEC also expressed LCAM-1, an adhesion molecule
participating in the interaction of antigen presenting cells and lympho-
cytes. Antibodies to ICAM-l inhibited the TEC-SED induced T-cell
proliferation. In summary, TEC presented superantigens thereby induc-
ing T-cell proliferation. Thus, we conclude that TEC may have the
potential to present antigens and to induce an immune response.
Morphological and immunocytochemical characterization of a rat
model of autosomal dominant polycystic kidney disease (ADPKD). Katrin
Schafer, Wilhelm Kriz, Norbert Gretz, Friedrich C. Luft, and Sebastian
Bachmann, Department of Anatomy, University of Heidelberg, Depart-
ment of Nephrology, University of Mannheim, Department of Neph-
rology, University of Erlangen, Germany. Homozygous and heterozy-
gous rats with ADPKD (new mutant of the Sprague-Dawley strain)
were investigated (clinical parameters, LM, immunohistochemistry,
EM). Homozygous animals died from uremia within the first 30 days (x
= 23 days, N = 70; serum urea 616 240 mg/dl; serum creatinine 2.4
1 mg/dl). Heterozygous animals rarely died before reaching 14
months of age. In 10-week-old males, serum urea levels were 80 to 120
mg/dl; serum cholesterol was increased (80 to 120 mg/dl). At 10 weeks
of age, kidney weight was doubled compared to unaffected controls (3.3
0.4 g vs. 1.4 1.1 g). Most of the cysts were located in the cortex, and
a few were found in the outer medulla. As revealed by immunohistochem-
istry, approximately 75% of the cysts were derived from the Pars recta of
the proximal tubule (labeling with anti-neutral-endopeptidase antibody),
approximately 10% originated from the distal tubule (labeling with anti-
Tamm-Horsfall protein antibody). The remaining cysts belonged to the
proximal convoluted part (presence of brush border) as well as to the
cortical collecting duct (presence of intercalated cells). In the distal tubule
and collecting duct system, reduced staining of Na,K-ATPase was de-
tected immunohistochemically; the signal was strictly localized to the
basolateral plasma membrane. Tubulocystic epithelium also exhibited
signs of simplification (loss of brush border, flattening of epithelial cells).
Thickening of tubular basement membrane was observed ultrastructurally;
focal increases in matrix expression were established using antibodies
against collagen IV and laminin. Conclusion: Changes in epithelial struc-
tural integrity, altered peritubular matrix expression and a presumptive
reduction in Na,K-ATPase content are the most prominent alterations in
this model of ADPKD.
Expression of multifunctional glycoproteins of the extracellular matrix
in autosomal dominant polycystic kidney disease (ADPKD). R. Klingel,
G. Ramadori, D. Schuppan, K.-H. Meyer zum Büschenfelde, and H.
KOhler, First Department of Internal Medicine, University of Mainz,
and Department of Internal Medicine, University of Berlin, Berlin,
Germany. The putative PKD1 gene on chromosome l6p represents the
genetic basis for 90% of patients affected by ADPKD. Although the
gene is not yet cloned, important pathogenic mechanisms could re-
cently be characterized. The process of cystogenesis dramatically alters
the normal tissue architecture of the human kidney. Micropapillary and
hyperplastic structures of cyst lining epithelia are associated with
molecular changes indicating an imbalance of growth and differentia-
tion. The expression of the epithelial developmental antigen EXO-l in
cyst lining epithelial cells and the growth factor receptor system of
EGF-receptor with its ligand TGF-alpha supported this concept. Cyst
walls of ADPKD kidneys are composed of dense connective tissue.
Alterations of epithelial-mesenchymal interactions mediated by multi-
functional glycoproteins of the extracellular matrix (ECM) may repre-
sent another major pathogenic mechanism underlying ADPKD. There-
fore, the distribution of multifunctional ECM glycoproteins undulin,
tenascin and fibronectin, interstitial collagens type I, III and VI, and
basement membrane components laminin and collagen type IV was
analyzed immunohistologically using specific monoclonal and polycy-
lonal antibodies. Fresh frozen tissue specimens of fetal kidneys (N = 5),
normal adult kidneys (N = 5), ADPKD kidneys (N = 4) and renal cell
carcinomas (N = 20) were investigated. In vitro normal kidney cells (N
= 2) and cyst lining epithelial cells (N = 3) were cultured to detect
mRNA levels of TGF-/3l, undulin and tenascin by Northern blot
analysis. Also, co-cultures of epithelial cells with autologous fibroblasts
were tested. Immunohistologically subepithelial layers of fibrous tissue
in cyst walls showed co-expression of undulin and tenascin. A similar
pattern was seen in renal cell carcinomas associated with areas of
papillary or cystic growth. In contrast, developmental stages of the fetal
kidney and the adult kidney showed a mutually exclusive distribution of
undulin and tenascin with unique patterns. In vitro the co-expression of
undulin and tenascin could not be imitated. Fibronectin and interstitial
collagens did not show specific patterns, but reflected the overall
increase of fibrosis in cyst walls. Co-expression of multifunctional ECM
glycoproteins undulin and tenascin in ADPKD kidneys and renal cell
carcinomas indicated an abnormal deposition of ECM components in
these benign and malignant situations of irregular growth in the human
kidney. Future investigations will address the role of fibrogenesis for
the process of cystogenesis and loss of renal function in human ADPKD
and will look for the possibility of a therapeutic approach based on
these findings.
Immunohistochemical detection of renin in kidneys of patients with
autosomal dominant polycystic kidney disease (ADPKD). M. Zeier, R.
Waldherr, M. Wiesel, andE. Ritz, Departments of Medicine, Pathology
and Urology, University of Heidelberg, Heidelberg, Germany. The
following findings suggest the interrelation of renal-renin system in
ADPKD: elevated circulating basal PRA-Ang II levels, increased
postcaptopril PRA, and increase of RPF after CE-inhibition in normo-
tensive carriers of the ADPKD trait. To further evaluate the renal-renin
system, we examined six patients with ADPKD and preterminal or
terminal renal failure in whom nephrectomy was performed as part of
pretransplantation workup. All patients had severe hypertension and
had antihypertensive therapy other than ACE-inhibitors. Immunhis-
tochemical detection of renin was performed using APAP-technique
and a monoclonal ab against human renin. Ten tumor nephrectomy
specimens were examined as control. We evaluated the juxtaglomerular
index (number of immunoreactive JGA/total number of glomeruli), and
number of cells positive for renin per JGA and renin in extraglomerular
structures. In ADPKD kidneys the median juxtaglomerular index was
23.8 (13.8 to 43.6) and was markedly higher than in controls (<10) in all
cases. The number of renin positive cells per JGA was significantly
higher. Cells staining for renin were also demonstrable in the vascular
walls of presumably stretched arterioles close to large cysts. Finally,
renin by was detectable in the apical pole of proximal tubular epithelial
cells of non-cystic tubuli and epithelial cells of cysts which exhibited
characteristics of proximal tubular epithelial cells. The study docu-
ments: (i) activation of renin despite hypertension in ADPKD patients
with renal failure; (ii) renin is also demonstrable in extraglomerular
structures.
Plasma angiotensin II (ANG II) and regulation of ANG II receptors in
patients with autosomal dominant polycystic kidney disease (ADPKD). A.
Klingbeil, M. Schmid, E. Ritz, J. Nussberger, and J. Mann, Depart-
ment of Medicine, University of Erlangen-Narnberg, Heidelberg, Ger-
many and Lausanne, Switzerland. Recent evidence indicates that ANG
II may play a role in hypertension of ADPKD. We investigated ANG II
and ANF-plasma levels and the regulation of ANG II and ANF
receptors on platelets in ADPKD patients (N = 9) with hypertension
and in matched healthy controls (CO, N = 9). We hypothesized that
ANG II receptor down-regulation may be impaired in ADPKD.
ADPKD patients and CO were studied after a 20 and a 200 mmol/l NaCI
diet (7 days each, random order). Plasma-ANG II and -ANF were
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measured by RIA after extraction, and platelet ANG II and ANF
receptors by radioligand binding. Plasma ANG II levels and receptor-
number and receptoraffinity were not different between ADPKD and
CO after a low and a high NaCI intake. The correlation between Plasma
ANG II levels and the number of ANG II receptors was not different
between groups (r = 0.8). Plasma ANG II levels were negatively
correlated with baseline GFR (C-inulin) in patients and the decrease of
plasma ANG II after a high NaCI intake was correlated with the
increase of GFR (r = 0.76). Plasma ANF levels were higher in ADPKD
than in CO after high (252 + 85 vs. 24 + 7 fmollml) and low NaCI intake
(43 + 11 vs. 15 + 4 fmollml); ANF plasma levels after high NaCI intake
were negatively correlated with GFR in patients. Number and affinity of
ANF receptors were not different between groups and exhibited no
change with NaC1 intake. The data show that ANG II formation and
receptor regulation is unaltered in ADPKD despite higher blood pres-
sure, volume retention, and activation of ANF without down-regulation
of ANF receptors. ANG II seems to be inadequately stimulated. The
findings support the hypothesis that ANG II contributes to high blood
pressure in ADPKD.
Polymorphism of phosphoglycolate phosphatase (PGP) for diagnosis of
autosomal dominant polycystic kidney disease (ADPKD). G. Kraatz, C.
Frenzel, P. Stöhlmacher, B. Jager, and D. Patzelt, Department of
Nephrology, University of Grefswa1d, Greifswald, Germany. The
mutation for ADPKD has been assigned to the short arm of chromo-
some 16. The close genetic linkage with the locus of erythrocytic PGP
has been demonstrated previously. The value of PGP phenotyping for
early diagnosis of ADPKD was checked in 154 persons of 20 families by
means of ADPKD (starch gel electrophoresis, zymogram technique).
Eight families were informed. The sensitivity of sonography correlates
with the age of the patients, while PGP-phenotyping has no relation to
the age of ADPKD gene carrier. A disadventage of PGP-phenotyping is
the relative low frequency of heterozygotes (25%) in Germany, whereas
the simplicity of the method is of advantage. The linkage analysis
showed a maximal load score of 3.2 and a recombination fraction of 0%.
One case is suspected for heterogeneity. The use of DNA diagnostic is
recommended if there is no PUP information.
Cytosolic free sodium is reduced in platelets of essential hypertensives.
studies with the new sodium sensitive fluorescent dye in intact cells. M.
Tepel, S. Bauer, S. Husseini, K.H. Rahn, and W. Zidek, Med.
Poliklinik, University of Münster, Minister, Germany. Intracellular
sodium concentration ([NaI1), cellular sodium metabolism, and tran-
port systems are linked to the pathogenesis of essential hypertension
and to established therapeutic interventions. The new non-destructive
fluorescent dye technique and sodium-binding-benzofuran-isophthalate
were used to measure [Na]1 in intact blood platelets of 20 essential
hypertensive patients (HT) and of 21 age-matched normotensive sub-
jects (NT). In situ calibration of the 340/385 nm excitation ratio in terms
of cytosolic free sodium concentration was performed on each platelet
preparation using ionophors. Resting [Na] was significantly reduced
in HT compared to NT (27.9 2.0mM vs. 35.8 2.2 mM, mean SEM,
P < 0.01). To evaluate an impairment of Na-K-ATPase in HT, platelets
were treated with 1 m ouabain for 60 minutes. Ouabain significantly
increased [Na]1 in both groups in a similar way, such as in HT to 57.9
7.0 mri (P <0.01 compared to resting value) and in NT to 55.1 5.3
mM (P < 0.01), respectively. After activation of Na-K-ATPase by
addition of 2 U/ml insulin, [Na] was 28.5 2.9 m in HT, and in NT
it was 27.9 2.9 m. Since increased activation of platelets by
thrombin is known in hypertension, platelets were stimulated by 0.15
U/mI thrombin. [Na] rapidly increased after addition of thrombin,
whereas both the rate and the extent of increase was similar in HT (24.4
3.0 mM) and NT (21.5 4.1 mM). It is concluded that measurements
in intact cells reveal results different from those obtained with destruc-
tive methods. Reduced cytosolic free sodium concentration in essential
hypertension may be due to different sodium metabolism distinct from
the Na-K-ATPase pathway.
Quantification of different intracellular calcium pools in vascular
smooth muscle cells from spontaneously hypertensive rats. M. Neusser,
M. Tepel, P. Golinski, Z. Zhu, K.H. Rahn, and W. Zidek, Med.
Poliklinik, University of Munster, Münster, Germany. The effects of
thapsigargin, a selective Ca-ATPase-inhibitor, and of angiotensin II on
intracellular calcium pools on vascular smooth muscle cells (VSMC)
from spontaneously hypertensive rats (SHR) and normotensive rats
(WKY) were investigated. VSMC from rat aorta were cultured on cover
slides, and cytosolic free calcium concentration ([Ca2],) was measured
using fura-2 after cells had been placed in a virtually calcium-free
puffer. Addition of 100 nM thapsigargin increased [Ca2]1 in VSMC
significantly more in SHR than in WKY [34.1 3.4 nM(N = 20) vs. 22.5
2.9 nM (N = 12), mean SEM, P < 0.02]. After thapsigargin-sensitive
calcium pools were exhausted, sequential addition of 100 nrt angioten-
sin II still caused a rise of [Ca2]1. Using SHR, the angiotensin II
induced rise of [Ca2], was not significantly different with or without
thapsigargin (51.9 9.6 flM (N = 20) vs. 48.5 5.5 ni (N = 21)). In
contrast, using WKY addition of angiotension II subsequent to thapsi-
gargin produced only a 45% rise of [Ca2], compared to addition of
angiotensin II alone [40.3 12.8 nM (N = 12) vs. 89.5 9.3 n (N =
17), P < 0.001]. The thapsigargin-sensitive calcium pools were in-
creased in VSMC from SHR. In VSMC from WKY thapsigargin-
sensitive calcium pools are a subgroup of angiotensin Il-sensitive pools.
In contrast, SHR have thapsigargin-sensitive calcium pools that cannot
be mobilized by angiotensin II. Thapsigargin-sensitive calcium pools
that were regulated by sarcoplasmatic Ca-ATPase may therefore con-
tribute to different calcium metabolism in hypertensive VSMC.
Progression of renal failure in transgenic rats carrying an addition
renin gent [TGR(mRen2)27]. J. Wagner, C.C. Haufe, A. Wystry-
chowski, D. Ganten, and E. Ritz, German Institute for High Blood
Pressure Research and Department of Nephrology, University of Jena
and Heidelberg, Germany. The renin-angiotensin system (RAS) has
been implicated in the progression of chronic renal disease. Therefore,
we examined if the presence of an additional renin gene influences the
course of renal failure after subtotal nephrectomy (SNX). Four-month-
old, female, ovariectomized, hypertensive transgenic rats (TGR), har-
boring the mouse Ren-2 gene, were compared to pressure-matched,
pairfed, stroke prone spontaneously hypertensive rats (SHR) 50 to 60
days after 70% subtotal nephrectomy. No significant differences in
blood pressure values were found at the beginning and at the end of the
experiment in SNX-rats, with values around 200 mm Hg. A strong
compensatory renal growth response, as indicated by the kidney/body
weight ratio, was found after SNX but did not vary significantly
between TGR and SHR rats. Creatinine in TGR-SNX rose to 0.83
0.06 mgldl (N = 12), compared to SHR-SNX (0.64 0.03 mg/dl; N =
11; F < 0.01). Glomerular filtration rate decreased to 934 206 liter/mm
in TGR-SNX, and 1210 205 liter/mm in SHR-SNX (NS). Plasma renin
and ANG II concentrations were similar in all SNX rats, but plasma
prorenin increased in the transgenic rats only, while it remained
unchanged in SHR. These data indicate that the expression of the
additional renin gene has no dramatic influence on evolution of renal
failure in a renal ablation model, but more subtle changes of renal
function cannot be excluded.
Regulation of glomerular angiotensinase A (ATA). G. Wolf, F. Thaiss,
C. Haas, U. Wenzel, W. Schoeppe, and R.A.K. Stahl, Department of
Nephrology, University Hospital Frankfurt, Frankfurt am Main, Ger-
many. The local glomerular concentration of angiotensin II (Ang II) is
regulated by its synthesis as well as the degredation of the peptide. The
peptidase ATA plays a pivotal role in the metabolism of Ang II. To
further study regulatory mechanisms of ATA, we measured ATA
enzyme activity and mRNA expression in glomeruli isolated from rats
4 and 12 weeks after 1 1/3 nephrectomy. Additional groups of animals
were treated with ramipril or the diuretic piretanid. Plasma renin was
significantly suppressed 4 and 12 weeks after renal ablation (controls
after 4 weeks: 10.6 3.8, 1 1/3 nephrectomy after 4 weeks: 4.9 0.34
ng A lIml x hr, N = 9, P < 0.01) whereas ramipril or piretanid induced
the predicted increase in renin activity. Renin transcripts were reduced
after kidney ablation but increased after ramipril or piretanid treatment.
Glomerular ATA activity was significantly enhanced in animals with
nephrectomy (controls after 4 weeks: 2.5 0.5 mU/mg protein, 1 1/3
nephrectomy after 4 weeks: 4.0 + 0.6 mU/mg protein, N = 6, P < 0.05).
Rampril treatment abolished this increase in ATA activity (nephrecto-
my with ramipril: 1.4 0.5 mU/mg protein, N = 6, P < 0.05). In
contrast, mRNA levels for ATA were significantly suppressed in
animals after nephrectomy but were enhanced after ramipril treatment
(Northern blot). Filters were rehybridized with GAPDH to proof that
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equal amounts of RNA were loaded. Our results suggest that the
increased ATA-activity in remant glomeruli is not caused by increases
in ATA transcripts. There seems to be a negative feedback between
enzyme activity and ATA mRNA. These complex regulatory mecha-
nisms may be important in the local metabolism of Ang II.
In situ characterization of renal angiotensin II (Ang II) receptors in
renovascular hypertension and chronic angiotensin converting enzyme
(ACE) blockade. M. Simon, E. Fuchs, and H.-J. Grone, Department of
Pathology, University of Gottingen and German Primate Center,
GOttingen, Germany. The vasoconstrictor Ang II contributes to the
establishment of renovascular hypertension. Ang II also exhibits comi-
togenic and hypertrophic characteristics. An inhibition of renal actions
of Ang II may lead to an atrophy of tubular epithelia. The aim of the
study was a qualitative and quantitative analysis of renal Ang II
receptors established in two kidneys: 1 clip hypertension (2K-1CH) and
in prolonged ACE inhibition of 2K-1CH with tubular atrophy of the
clipped kidney. After clipping the left renal artery ( 0.2 mm) and four
weeks of arterial hypertension (systolic arterial pressure  160 mm Hg)
male Wistar rats were treated with (group I, N 6) and without (group
II, N = 6) enalapril (5 mg/kg body wt/day). Kidneys of untreated
normotensive rats served as controls (group II, N = 3). Localization,
specific maximal binding (Bmax) and affinity (Kd) of 125! Ang II binding
sites (BS) were determined by quantitative in vitro autoradiography.
Competitors taken were: Ang II, Ang III, haloperidol, propanolol, the
Ang II receptor antagonists DuP 753 and PD 123177. Rat kidneys
showed specific Ang II BS in glomeruli, cortex and medulla. Glomeruli
had a fourfold and tenfold higher Bmax than medulla and cortico-
interstitial compartment. Cortex demonstrated the highest Ang II
binding affinity. Ang II BS were blocked by DuP 753, a specific AT1
receptor antagonist, not by PD 123177, a specific AT2 receptor antag-
onist (IC 50 DuP 753, glomeruli: 23 3 nmol). In 2K-ICH and salt
depletion Kd differences of Ang II BS were not found between clipped
and contralateral kidneys. Bmax was higher in the clipped than in the
contralateral kidney. Enalapril led to a significant increase of Bmax in
cortex and medulla [clipped kidney cortex: 6.01 0.84(I) vs. 9.2 1.52(II); medulla: 11.91 2.36 (I) vs. 20.37 3.58 (II) fmol/mg]. Rat
kidneys have the ATI receptor subtype. In renovascular hypertension,
no change of affinity of Ang II BS could be demonstrated but maximal
binding of the tubulo-interstitium of the clipped kidney increased and
rose even further during prolonged ACE therapy. This may be inter-
preted as a counter regulatory action to atrophy and the deficiency of a
trophic effect of Ang II.
Modulation of cardiovascular angiotensin converting enzyme (ACE) in
renovascular hypertension. Karin Jandeleit, M. Hettiarachchi, B. Jack-
son, and C. Johnston. The University of Melbourne, Department of
Medicine, Austin Hospital, Heidelberg, Australia, and Hannover Med-
ical School, Department of Medicine, Division of Nephrologie, Han-
nover, Germany. It has been suggested that the increased tissue
renin-angiotensin system (RAS) might be involved in the maintenance
of hypertension in renovascular hypertention. The present study was
aimed to measure ACE concentration in mesentenc vessel membrane
homogenates and in the left ventricle in two different forms of renovas-
cular hypertension. Methods: Renovascular hypertension was induced
by clipping the left renal artery (2 kidney, I clip, 2K1C, controls: 2
kidney, 0 clip, 2KOC) plus nephrectomy on the right side (1 kidney, I
clip, 1K1C, controls: 1 kidney, 0 clip, 1KOC). ACE concentration
(Bmax) was measured in homogenates of mesenteric vessel membrane
and left ventricular homogenates utilizing a radioligand binding assay
with MK 351 A as the specific radioligand. Results: (1) Eight weeks after
operation there was a similar rise of blood pressure in the 2K 1 C and the
IKIC group. (2) Plasma renin activity was increased in the 2K1C group
and suppressed in the IK1C group. (3) Hypertension was associated
with cardiovascular hypertrophy in both Goldblatt models [mesentery:
0.3 mg/g (2K1C) vs. 0.11 mg/g (2KOC), 0.36 mglg (1K1C) vs. 0.24 mg/g
(1KOC); left ventricle: 5.2 mg/g (2K1C) vs. 3.4 mg/g (2KOC), 5.6 mg/g(IK1C) vs. 3.3 mg/g (IKOC)1. (4) Only in the IK1C model with
suppressed renin did we measure a significant increased in the ACE
concentration of mesenteric vessel and left ventricular homogenates
which correlated with the degree of hypertrophy. These results indicate
that cardiovascular ACE in these two different models of renovascular
hypertension is not only modulated by the degree of hypertension and
hypertrophy, but also by other factors (activity of the circulating RAS).
Pressure-dependent renin release (PDRR) in experimental nephroscle-
rosis (NS). G. Schwietzer, Andrea Schdtzler, U.O. Wenzel, E. Hack-
enthal, U. Helmchen, and W. Schoeppe, Division of Nephrology,
University of Frankfurt/M, Institute of Pharmacology, University of
Heidelberg and Institute of Pathology, University of Hamburg, Ger-
many. Despite a normal or decreased renin content in the unclamped
kidney of 2K1C-hypertension (RVH), PDRR during blood pressure
reduction may be increased due to vascular stenotic lesions, thus
attenuating the efficacy of antihypertensive therapy. Therefore, we
studied PDRR in rats 4 (RVH-1) and 12 weeks (RVH-2) after develop-
ment of RVH by lowering renal perfusion pressure (RAP, range = 40 to
120 mm Hg) using nitroprusside (NP) or suprarenal aortic constriction
(AC) with and without Captopril (ACE!) one week after removal of the
clamped kidney. At each RAP-step, plasma renin concentration (PRC)
was measured. Individual RAP/PRC-curves were calculated and the
slope was taken as a measure of PDRR. Medial area (S) of small
intrarenal arteries was determined morphometrically.
SLOPE (ng Al/mI/hr x mm Hg)
AC +
PRCO NP AC ACE!
Controls 47 7 5.2 1.3 4.4 1.2 20 7
(12)
RVH-1 35 6 1.7 0.5a 1.5 0.4a 8 4
(10)
RVH-2 21 4 0.9 04ab 0.9 0.4a 5 2a
(11)
PRCO = ng AI/ml/hr; a P < 0.05 vs. controls; bP < 0.05 vs. RVH-1.
After AC EL, the slope of PDRR in RVH-groups was equally reduced at
RAP = 60 to 80 mm Hg vs. controls. However, at RAP < 60 mm Hg,
the slope was not significantly different from zero in RVH-rats only.
Furthermore, PRC0 and PDRR-slope were positively correlated. Indi-
vidual S-values were inversely related to slope-values of PDRR and to
PRC0-values. In conclusion, PDRR before and after ACE! is diminished
in chronic NS despite vascular hypertrophy and, hence, is probably not
a factor in the maintenance of RVH during acute BP reductions.
Combination therapy of nitrendipine with enlaparil improves renal
function in rats with nephrosclerosis. U. Wenzel, H. Palluck, U.
Helmchen, W. Schoeppe, and G. Schwietzer, Department of Nephrol-
ogy and Pathology, University of Frankfurt/Main and Hamburg, Ger-
many. In a rat model of RVH we have recently demonstrated that
nitrendipine (NIT) aggravates proteinuria and glomerular damage. NIT,
however, did not normalize blood pressure (SBP). In order to test
wether the effect of NIT could be ameliorated by achieving normal
SPB, we treated rats with the combination of enalapril (ENP) + NIT
and ENP + hydrochlorothiazide (HCTZ) and with ENP and NIT alone
in comparison to hypertensive controls (HC). After six weeks albumin-
uria (ALB), GFR, glomerular size (GLOM) and sclerosis (GS) were
analyzed.
SBP
mm Hg
ALB
mg/24 hr
HC 187±9 8.0±5.0
NIT 175 4 20.5 4.o
ENP 142 6 2.1 0.5
ENP+NIT 116 3b 0.5 OF'
ENP+HCT 112 3' 0.5 01b
GFR GLOM GS
mI/mm 108 m5 score
2.0 0.3 1.1 0.1 1.4 0.2
3.8 0.6k' 1.6 o.l 1.7 0.2
2.0 0.3 1.2 0.1 0.9 0.3
2.8 0.4 1.2 0.1 0.4
2.5 0.3 1.2 0.1 0.3 01b
Mean SEM, a P < oo5, "P < 0.001 vs. HC.
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Adverse renal effects of NIT were abolished by the combination of
ENP+NIT and ENP+HCTZ were equally effective in reducing SBP,
ALB and GS but were better than ENP alone. We conclude that the
combination of a converting enzyme inhibitor (CEI) + a calcium
channel blocker (CCB) may abolish adverse renal effects following the
CCB alone by lowering SBP to normal, and CEI combined with CCB or
with a diuretic is equally effective in lowering SBP and renal protection
in RVH, but is superior to CEI alone. Therefore, strict blood pressure
control (only obtained by combination therapy) is necessary for neph-
roprotection in this model of hypertension.
ACE-inhibition and ANF in the brains of 5/6 NPX rats. H. Geiger, U.
Bahner, Iris Kraus, Marion Hofmann, M. Palkovits, A. Heidiand, and
F.C. Luft, Universities of Eriangen and Wurzburg, Germany, and
NIMH, Bethesda, Maryland, USA. Atrial natriuretic factor (ANF) may
operate in conjunction with angiotensin (ANG) in the perifornical area
(P) to influence salt and water homeostasis. We tested this relationship
in normal and 5/6 NPX rats. Rats were killed 12 days after NPX and
after 5 days lisinopril (L). ANF was measured in plasma and 16 brain
nuclei. Representative mean data are below:
BP
mm Hg
UV
ml
Na
mmol/liter
ANF
pg/mi
PANF
pg/mg
sham 120 9 147 117 73
5/6 l50 37 138 107 ll3
5/6+L 110 2l l49 25 65
a P < 0.05 vs. sham, ANOVA
ANF was also increased in the AV3V, arcuate, and dorsal raphe with
NPX. L decreased these values. Drinking increased with NPX but
decreased with NPX+L. The data show that NPX increases BP,
drinking, and PANF, while ANF is unchanged. L decreases BP, UV,
drinking, and ANF, while it restores PANF values. The data support an
interrelationship between ANG and ANF in the brain with respect to
BP and Na homeostasis. The role of ANF in the brain may be quite
different than in the peripheral circulation.
Blood pressure reduction in normotensives after high sodium intake is
associated with reduced renal sodium and water excretion and plasma
ANP. B.O. Göbei, N. Hittel, R. Kolloch, A. Overlack, M. Ruppert, K.
Kraft, R. Düsing, K.O. Stumpe, Med. Universitats-Poiiklinik, Bonn,
Germany. Objective: The response of arterial blood pressure (BP) to
high salt intake (HS) within an unselected population follows a Gaus-
sian distribution. In the present study, renal sodium and water handling
in subjects at both edges of this distribution was evaluated. Methods:
We studied 35 salt-sensitive adults (SS) known to increase their BP after
HS and to decrease their BP after low salt intake (LS) and compared
them with 28 counter regulators (CR) showing the opposite BP response
to HS and LS. HS (320 mmol Na/day) and LS (20 mmol Na/day)
were given in random order for one week each. Renal function and
concentrations of plasma ANP and plasma aldosterone (A) were
assessed on the seventh day of the respective diet period. Results: CR
had lower BP during HS (P < 0.001) and higher BP during LS (P <
0.01). CR had a lower fractional water excretion than SS both after LS
(0.99 0.38 vs. 1.37 0.52%; P = 0.01) and HS (1.16 0.48 vs. 1.44
0.54, P = 0.05) and a lower fractional sodium excretion than SS after
LS (P = 0.02). Negative free water clearance (TCH20) was higher in CR
both after HS (P = 0.007) and LS (P = 0.015). urine volume was lower
in CR both after HS and LS (P < 0.05). The creatinine clearance was
not different between the groups both after LS and HS. CR had lower
ANP but higher A after HS as compared to SS. Conclusions: The
hypotensive responses to HS in CR and to LS in SS cannot be due to
changes in renal function and ANP or A concentrations. Also, the data
challenge the concept that salt sensitivity is related to impaired kidney
function and/or ANP and A secretion.
Insulin resistance and salt sensitivity. A .M. Sharma, Ulrike Schorr, E.
Wengerzink, A. Distler, Department of Nephrology, Klinikum Steglitz,
Free University of Berlin, Germany. We have recently reported a
hyperinsulinemic response to an oral glucose load in salt-sensitive
normotensive subjects, suggesting that insulin resistance may be
present in these hypertension-prone individuals prior to the develop-
ment of hypertension. In the present study we therefore estimated
insulin sensitivity by the "Insulin Suppression Test," that is by
measuring the plasma glucose and insulin concentration during a 180
minute infusion of glucose (150 mg/m2/min), insulin (24 mU/m2/rnin) and
somatostatin (350 jig/hr) in 18 healthy male volunteers (age: 21 to 28
years) given a standardized low salt diet (20 rnrnol/day) for two weeks,
supplemented either by 220 mmol NaCI/day or placebo, in a single blind
randomized cross-over order for one week each. As in previous studies
salt sensitivity was defined as a significant decrease in mean arterial
blood pressure greater than 3 mm Hg (P< 0.05) under the low salt diet.
By this definition seven of the 18 subjects were salt sensitive. There was
no difference in age (24.4 1.7 vs. 25.6 3.1 years) or body mass index
(22.2 2.0vs. 22.1 1.4kg/rn2) between the two groups. While insulin
infusion resulted in similar plasma insulin levels (about 50 mU/liter),
concomitant glucose infusion resulted in plasma glucose levels that
were more than 50% higher in the salt-sensitive than in the salt-resistant
group (P < 0.005). Our data show that insulin-mediated glucose
disposal is reduced in otherwise healthy lean normotensive salt-sensi-
tive subjects, indicating that insulin resistance is present in these
hypertension-prone individuals prior to the development of hyperten-
sion.
Reduction of microalbuminuria in essential hypertension by different
antihypertensive drugs regardless of changes in renal hemodynamics.
Christiane M. Erley, Uwe Haefele, Nils Heyne, Norbert Braun, and
TeutRisler, University of Tuebingen, Department of Internal Medicine,
Tuebingen, Germany. Microalbuminuria in patients with essential hy-
pertension (EH) is associated with hypertensive organ damage and an
increase of cardiovascular morbidity and mortality. Within the kidney
microalbuminuria seems to reflect an increase of glomerular filtration
pressure. We studied the effects of four different antihypertensive drugs
regarding the reduction of urinary albumin excretion (UAE) and
changes in renal hemodynamics. In a double-blind, cross-over study (10
female, 7 male; age 39 14 yrs) we prospectively measured UAE prior
to and after 12 weeks of treatment and two weeks of placebo, respec-
tively, with either ramipril (R, mean dosage 5 mg/day), metoprolol (M,
85 mg/day), felodipin (F, 8 mg/day) or doxazosin (D, 2 mg/day).
Additionally we measured renal hemodynamics by continuous inulin-
and PAH-clearance and UAE at the end of each treatment period and
after two subsequent four-week placebo periods at the beginning and at
the end of the study [placebo period 1 (P1) and 6 (P6)].
P1 R M
UAE mg/day 46 49 16 l6 14 l2
MAP mm Hg 116± 5 102 101 5a
GFRm1/min 112 17 115 21 110 29
RPFm//min 553 84 544 110 516 133
FF % RPF 20 0.4 21 0.5 22 0.3
F D P6
18 23 14 l4 40 46
101 5" 102 5" 110 6
114±27 111±19 ND
526 119 521 114 ND
22±0.5 22 ND
All four antihypertensive drugs showed a comparable reduction on
UAE related to reduction in MAP, regardless of different influences on
renal hemodynamics. ("P < 0.05 compared to placebo)
Nocturnal blood pressure increase in patients suffering from cerebral
ischemia. J. Schrader, A. Doutheil, G. Schoel, M. Holzgraefe, R.
Heydenbluth, K. Feigenhauer, and F. Scheler, Med. University Kiinik,
Department of Nephroiogy/Rheumatology, Department of Neurology,
Goettingen, Germany. In a prospective study incidence and prognosis
of a blunted circadian blood pressure (b.p.) rhythm during 24 hours
blood pressure monitoring (24 hr BPM) was investigated in patients
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with cerebral ischemia. One hundred twenty-one patients (61.2% with
cerebral stroke, 38.8% with transient ischemia) were included in the
study. Sixty-two percent were male patients. The mean age was 64.8
years. Hypertension was known before in 62.8% of the patients,
diabetes mellitus in 33.9%, hypercholesterinemia in 48.8%, and 22.3%
were smokers. During 24 hr BPM, only 44 patients demonstrated a
normal nocturnal b.p. decrease of more than 10% of the daytime b.p.
value. Of the 77 patients without significant b.p. decrease during the
nighttime, 23 patients even showed a nocturnal blood pressure increase.
There were no differences between the groups with and without
nocturnal b.p. decrease in the frequency of hypertension, diabetes,
hypercholesterinemia or smokers. But significantly more patients with
cerebral stroke were found in the group with nocturnal b.p. increase.
During a follow-up period of 14.3 months the incidence of cardio- and
cerebrovascular events was studied and related to the b.p. rhythm. In
23 patients further vascular events were observed. Patients with an
increase of b.p. at night had a significantly higher rate of vascular events
than patients with a normal nocturnal b.p. decrease. These results
demonstrate a high incidence of disorders of the 24 hr b.p. rhythm in
patients after acute cerebral ischemia, and this seems to worsen
patients prognosis.
Glomerular hypertrophy is not a necessary prerequisite for focal
glomerular sclerosis in subtotally nephrectomized rats. Raimund Hirsch-
berg and Cynthia Nast, Division of Nephrology, Harbor-UCLA Med-
ical Center and Department of Pathology, Cedar-Sinai Medical Center,
UCLA, Los Angeles, California, USA. After subtotal nephrectomy,
rats develop progressive segmental glomerular sclerosis (FGS) of
remnant nephrons, which is accelerated by feeding high protein diets
(HP) and ameliorated with low protein diets (LP). In this and other
models of renal disease, hemodynamic changes, metabolic events, and
particularly hypertrophy of the remnant nephrons are all believed to
contribute to FGS. The present study was performed to examine the
relationship between glomerular hypertrophy and FGS in experimental
renal failure. Rats were 5/6 nephrectomized and pair-fed either a HP
diet (36%) or LP diet (9%) and received treatment for 28 to 35 days with
either (N = 7 per group): LP+Vehicle, LP+IGF-I (50 tg tid s.c.),
HP+OC (Octreotide, a somatostatin analogue, SO g bid s.c.) or
HP+ Vehicle. The determinants of glomerular ultrafiltration were mea-
sured by micropuncture. Glomerular hypertrophy was assessed by
measurement of glomerular tuft volume (GlomVol) and by glomerular
Prot/DNA ratio. Glomerular collagen I and IV (ELISAs), the procolla-
gen (PC) alphal (IV) mRNA (Slot Blot) and the % of glomeruli with
FGS (histology) were also assessed.
P0
mm Hg
SNGFR
ni/mm
Glom
Vol
xJ06
,m3
Prot/
DNS
LP
LP+IFG-I
HP+OC
HP
58
62
63
67
51
58
57
65k'
0.482
0.968a
0.578
0.9l3a
23.3
333a
25.3
36.7a
CoIl-I
,ug/mg
Coll-IV
Prot
FGS
%
PCa1(IV)
mRNA
%
1.1
1.5
1.7
4.oa
3.9
6.2a
lo.2a
lo.la
1.0
2.9
14.8a
l3.5'
100
212
41l
404k
Data are mean; a < 0.05 vs. LP
HP+ Vehicle and LP+IGF-I rats have a similar degree of glomerular
hypertrophy, but the latter are largely spared from sclerosis. In con-
trast, OC, which prevents the HP-induced glomerular hypertrophy,
does not reduce FGS. We conclude that glomerular hypertrophy does
not predict FGS in subtotally nephrectomized rats.
Modulation of renal hypertrophy by intracellular proteinases. Lii iana
Schaefer, R.M. Schaefer, and A. Heidiand, Department of Nephrol-
ogy, University of Wuerzburg, Germany. Chronic renal failure is
accompanied by alterations in the activities of glomerular and tubular
proteinases. In the present study male Wistar rats underwent 5/6
nephrectomy (5/6-NX), and after 16 weeks glomeruli and tubules were
isolated and proteinase activities determined with the use of fluorogenic
substrates. In the remnant kidney intraglomerular collagenase (5/6-NX:
20 6 vs. SHAM: 53 = 6 mU/zg DNA) and gelatinase activities
(5/6-NX: 24 5 vs. SHAM: 131 8 F/1.tg DNA) were reduced. A
similar pattern was observed for tubular cathepsins (Cath-L: 5/6-NX: 8
2 vs. SHAM: 24 1; Cath-B: 5/6-NX: 5 I vs. SHAM: 12 1;
Cath-H: 5/6-NX: 3 I vs. SHAM: 7 1 nM/min/Lg DNA). Protein
restriction (5% casein) considerably attenuated hypertrophy of the
remnant kidney, while glomerular and tubular proteinase activities
increased. Besides protein restriction, treatment with Enalapril (E) and
Verapamil (V) reduced renal hypertrophy and stimulated glomerular
(5/6-NS+E+V: Gelatinase: 37 3 vt. 5/6-NX: 26 3 F/p.g DNA) and
tubular (5/6-NX+E+V: Cath-L: 18 I vs. 5/6-NX: 8 2 nM/min/g
DNA) proteinases. These findings show that renal hypertrophy is
associated with a decline in glomerular as well as tubular proteinase
while manipulations which prevent hypertrophy simulta-
neously stimulate these enzymes.
Focal segmental glomeruloscierosis (FSGS): A disease of the podocytes?
E. Kemeny, M.J. Mihatsch, U. Dürmuller, and F. Gudat Institute of
Pathology, University of Basel, Basel, Switzerland. Podocytes in FSGS
show swelling, vacuolization, protein droplets and detachment from the
glomerular basement membrane (GBM). We studied one case of
recurrent FSGS developed in renal transplant by immunofluorescence
and PAS utilizing a panel of antibodies against integrins and compo-
nents of the cytoskeleton and the extracellular matrix. Podocytes in
glomeruli without FSGS lesions showed normal integrin distribution:
a3f31 was expressed strongly and a5/3l moderately in a basally polar-
ized manner. The antibody against the vitronectin receptor showed
weak labeling co-lining with the GBM. In the area of FSGS lesions two
major patterns of integrin expression was observed in podocytes, which
for the most part showed correlation with early and advanced stages of
the disease. a5/31 displayed a gradual loss of expression in early stage
and became undetectable in advanced FSGS. a313l and the vitronectin
receptor (33) showed redistribution; in early stage they lost their
polarized expression and were detected intracellularly, while in ad-
vanced stage both integrins became polarized to the basal surfaces of
podocytes with occasional basolateral positivity. In addition, they
showed a reversed expression, and reactivity for a3/31 got markedly
decreased, while staining for the vitronectin receptor became signifi-
cantly enhanced, which was most prominently seen in advanced FSGS.
Most of the podocytes in early FSGS also transiently expressed the
HAR/GP9O collagen receptor and/or showed rearrangement in actin
distribution. The pp44 cytoskeleton associated podocyte antigen was
undetectable in FSGS lesions. Podocytes also showed an altered matrix
synthesis. Based on these results we propose that podocytes loose their
adhesive phenotype in early FSGS which may result in the detachment
of podocytes from the GBM.
Altered glomerular extracellular matrix (ECM) synthesis in experimen-
tal membranous nephropathy (MN). J. Floege, R.J. Johnson, A.
Yoshimura, C.F. Aipers, and W.G. Couser, University of Seattle,
Washington, USA. Chronic MN in man is characterized by thickening
of the glomerular basement membrane (GBM) with formation of spikes
which contain laminin and other ECM proteins. We have investigated
the changes in GBM composition in two models of MN in the rat (active
and passive Heymann nephritis, AICN, PHN). Renal biopsies obtained
during AICN and PHN were immunostained for various ECM proteins
and glomerular RNA was hybridized with cDNA probes specific for
laminin B2-chain, s-laminin, and types I and IV collagen. In addition,
the ability of anti-glomerular epithelial cell (GEC) antibody and com-
plement on rat GEC in culture to induce laminin release or laminin and
s-laminin mRNA expression was determined. The results show that at
weeks 12, 16, and 20 of AICN, immunostaining for laminin, s-laminin,
fibronectin, entactin, and heparan sulfate proteoglycan increased in the
GBM in a spike-like pattern. Concomitantly, glomerular mRNA levels
of laminin B2-chain and of s-laminin increased. Type IV collagen
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protein and gene expression remained unchanged or decreased. No
glomerular immunostaining for type I collagen occurred during AICN,
despite increased expression of mRNA for this collagen type. In
contrast to AICN, in PHN no pronounced changes of the glomerular
ECM occurred, except for transient glomerular expression of type I
collagen mRNA and type I collagen protein in the GEC cytoplasm.
Stimulation of GEC in culture with anti-GEC antibody and complement
failed to induce transcription of laminin or s-laminin mRNA or the
release of laminin protein. These findings suggest that the polyantigenic
expansion of GBM in experimental MN may be stimulated by factors
different from the C5b-9 mediated processes that cause the initial
proteinuria.
Increase of glomerulosclerosis (GS) induced by fish oil diet (FO) in
Milan normotensive rats (MNR): Hemodynamic and morphometric in-
vestigations. R. Brunkhorst, H. POtschik, G. Ehierding, V. Kliem, K.
Neumann, and K.M. Koch, Department of Nephrology, Medizinische
Hochschule Hannover, Hannover, Germany. MNR spontaneously de-
velop proteinuria (PU) and GS in early life. A protein restricted diet
significantly reduced GS, whereas ACE-inhibition showed no protec-
tive effects in this normotensive rat strain. In other animal models with
GS, FO influenced renal hemodynamics and reduced GS by changing
prostaglandin metabolism. We investigated kidney weight (KW), GFR
(inulin clearance), RBF (electromagnetic flow at the renal artery), PU
(Biuret), index of GS (light microscopy; SI), glomerular volume (mor-
phometry; GV) and PgE2-excretion (RIA) in two groups of MNR with
FO-diet (N = 7 each) and in two groups of MNR with control diet
(CON, N = 7 each). In one FO- and one CON-group parameters were
investigated after two weeks of diet, in the remaining two groups after
25 weeks of CON- and P0-diet, respectively.
RBF
mi/minig KW
KW
re Niere, g
FO
CON
3.8 0.8
5.6 0.9
2.65 0.19
2.1 0.1
PU
mg/24 hr
SI
%
GFR
mi/minlg KW
176.4 33
82.8 41
60.3 6
39.7 6
0.18 0.05
0.30 0.05
After two weeks FO-rats showed a significant (P < 0.05) increase of
RBF and PgE2-excretion compared to CON-rats; all other parameters
did not differ significantly. After 25 weeks FO-rats had a significantly
higher PU and GS, RBF and GFR were significantly reduced (Table).
GV was not significantly different between FO- and CON rats. Chronic
FO-diet induced an increase of PU and GS. This surprising observation
might be caused by hemodynamic alterations in the early phase of the
FO-treatment. Glomerular hypertrophy did not occur after either two or
25 weeks of FO. The pathogenetic role of the relative increase of
tubulointerstitial volume (increase of KW and unchanged GV) remains
to be investigated further.
Mitigation of diabetic renal hypertrophy by starvation: The role of
intralysosomal proteinases in kidney cortex. C.J. 0/brichi, Beare Geiss-
inger, and K.M. Koch, Division of Nephrology, Medical School Han-
nover, Hannover, Germany. In renal hypertrophy of early diabetes
mellitus (DM), the kidney protein mass is increased. This may be due to
increased protein synthesis or decreased protein breakdown. The
lysosomal proteinases cathepsin B and L (CAT) are major enzymes
involved in intracellular protein degradation. To evaluate the role of
protein breakdown in the development of diabetic renal hypertrophy we
measured the activity of CAT in kidney cortex. Four groups of age
matched rats were studied. (1) Sham injected controls. (2) Ten days
after induction of DM by i,v. injection of streptozotocin, 60 mg/kg. (3)
DM rats with insulin, 2 x 4 U per day. (4) DM rats with starvation at
day 2, 5, and 9, since intermittent starvation increases CAT activities.
Protein
Group N
Kidney
weight
mg
per
kidney
mg
Cathepsin B+L
nmol/min/mg
protein
Control 12 744 5l 87 ioa 174 l8
Diabetes 10 945 93 104 11 131 31
Insulin 7 809 47 81 l9 223 83
Starvation 8 737 88 91 6 186 ba
Values are mean SD; a p < 0.05 versus DM rats.
The increase in kidney weight in diabetic rats was prevented by insulin
and by three days of starvation during the ten days experiment.
Cathepsin B and L activity were decreased in the kidney cortex of
diabetic rats, while insulin and starvation prevented the decrease in
enzyme activity. We conclude that reduced intracellular proteolytic
activity and reduced protein degradation may be responsible for dia-
betic renal hypertrophy.
Do alterations in sorbitol metabolism participate in the pathogenesis of
renal lesions in diabetes? R. W. Grunewald, Julia M. Grunewald, Chris-
tine SchwOrbel, and H.E. Franz, Sektion Nephrologie, Universitdtsk-
linik U/rn, Ulm, Germany. Altered metabolism of organic osmolytes
(sorbitol, inositol, betaine, glycerophosphoryl choline) is thought to be
responsible in part for diabetic complications (such as cataract, neu-
ropathy). Since these osmolytes are known to be important during
osmoregulation of inner medullary collecting duct (IMCD) cells, the
influence of increased sorbitol synthesis in diabetes mellitus was
investigated. In papillae of diabetic Wistar rats total content of organic
osmolytes was increased by 20% from 423 29 to 509 12 tmol/g
protein. Freshly isolated IMCD cells were therefore incubated for three
hours in presence of 5 m (control, C) and 50 m glucose (diabetes, D)
to achieve similar composition. The cell volume was then increased by
27 4% [2.93 0.40 (D) vs. 2.31 0.35 (C) ml/g protein]. Additionally,
the influence of sorbitol metabolism on the regulation of the Na-K-
ATPase was investigated. The ion content (Na, K, Cl) increased by 11
3% [1459 68 (D) vs. 1319 86 (C) mmol/kg dry weight], and the
Na/K ratio increased from 0.32 (K) to 0.47 (D). The Na-K-ATPase
activity decreased significantly [260 62 (D) vs. 350 17 (C) U/g
proteini. Thus, increased sorbitol synthesis in diabetes mellitus in
IMCD cells leads to increased content of osmolytes and decreased
Na-K-ATPase activity. Therefore, the Na/K gradient is altered and cell
swelling occurs. This might considerably participate in the pathogenesis
of necrosis of the papilla in diabetes.
LDL uptake and cholesterol metabolism in mesangial cells. Annette
Kramer, H. Pavenstadt, M. Nauck, H. Wieland, P. Schollmeyer, C.
Wanner, Department of Medicine, Divisions of Nephrology and Clini-
cal Chemistry, University of Freiburg, Freiburg, Germany. There is
accumulating evidence that glomerular lipid accumulation is an inde-
pendent risk factor in the pathogenesis of focal glomerulosclerosis in
humans and in experimental models of chronic renal disease. Since
lipoprotein metabolism is different in rodents and humans, we com-
pared LDL uptake and intracellular cholesterol metabolism in RMC and
human mesangial cells (HMC). RMC and HMC were obtained by sieve
technique. Characterization was performed immunologically by the
peroxidase/antiperoxidase method. Human LDL was isolated by se-
quential ultracentrifugation and labeled with 1251 to determine binding,
internalisation and degradation capacities. Cholesterol synthesis was
determined by measuring suppression of '4C-acetate incorporation in
sterols, and cholesterol esterification was quantitated by measuring the
stimulation of cholesteryl ester formation by LDL. Uptake of LDL in
both RMC and HMC occurred in a receptor-specific and concentration
dependent manner, and the process was saturable. However, RMC and
HMC showed significant differences in uptake specificity (42 vs. 87%),
receptor affinity (K,,: 213 vs. 16 g protein/mI medium) and maximal
degradation capacity (Vmax: 841 vs. 3636 ng/mg cell protein) of LDL. In
addition, HMC showed an almost fourfold suppression in intracellular
sterol synthesis and enhanced cholesteryl ester formation compared to
RMC. Conclusion: The present data confirm recent results obtained in
RMC, but demonstrate a low receptor-specificity for LDL in RMC.
HMC exhibit significantly higher specificity, affinity and maximal
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capacities for LDL. Therefore, HMC should be preferred over RMC
when investigating the potential role of lipoproteins in mediating
glomerular injury and progression of renal disease.
Amelioration of lipid glomerulopathy by the HMG-COA reductase
inhibitor lovastatin in guinea pigs. An effect without overt reduction in
plasma cholesterol levels. H.-J. GrOne, B. Miller, A.K. Wa/li, T. Eisen-
hauer, Elisabeth GrOne, and D. Seidel, Institutes of Pathology and
Clinical Chemistry, Universities of GOttingen and Munich, Germany.
Deposition of lipids in glomeruli with ensuing glomerulosclerosis can
occur in hyperlipidemia in several mammals. Lipid glomerulopathy may
also contribute to the progression of glomerular disease in humans. The
aim of the study was to investigate if the HMB-CoA reductase inhibitor
lovastatin could influence lipid glomerulopathy by a reduction in plasma
cholesterol levels. Male guinea pigs were used, as their plasma lipopro-
tein profile is qualitatively similar to that of humans. Animals were
unilaterally nephrectomized to accentuate glomerular damage. The
guinea pigs were fed a diet with and without 0.3% cholesterol for two,
five, and eight months. Lovastatin was administered to two groups of
animals in each diet at a dose of 25 mg and 50 mg/kg body wt/day (12
animals in every group). Cholesterol feeding increased plasma choles-
terol levels from 68 4 mg/dl to 242 33 mg!dl. Lovastatin at low
dosage did not reduce plasma cholesterol levels significantly, but at
higher dosage a reduction in plasma total and LDL cholesterol levels of
26 and 24%, respectively was observed. Lovastatin did not alter
lipoprotein receptor activity in hepatic and renal membranes. No
significant alternations in lipid-protein composition of lipoprotein sub-
classes were noted during lovastatin therapy. Lipid-induced glomerul-
opathy regressed in both groups of cholesterol fed lovastatin treated
animals. In the low-dose lovastatin group the decrease in lipids per
glomerular surface area (GSA) by 75 10% was 46 11 and 37 5%,
respectively at eight months. Mesangial sclerosis index also decreased
from 3.2 0.7 to 1.2 0.4 as compared to cholesterol fed untreated
animals. It appears that a reduction in glomerulopathy and glomerular
cell proliferation by lovastatin could be dissociated from its overt effect
on lipids. Our data suggest that the antiproliferative effect of lovastatin,
already reported for cultured smooth muscle cells, may inhibit the
development of glomerulosclerosis.
Long-term renal function after uninephrectomy. V. Schumann, M.
Goebel, B. Kosanke, M. Claus, E. Fritschka, K. Wagner, and Th.
Philipp, Departments of Nephrology and Urology, University of Essen,
Essen, Germany. After uninephrectomy hyperfiltration of the single
kidney is a common feature. We investigated the renal function of 94
patients (age 57.5 9.5 years) after long-term uninephrectomy (10.8
5.7 years). The most frequent cause of uninephrectomy was a renal
cancer (60%). The following parameters were investigated: 24 hour
blood pressure monitoring, 2 x 2 hr creatinine clearance, determination
of the proteinuria (albumin, IgG, alpha-2-macroglobulin, total protein)
and of enzymuria (LDH, LAP, gamma-GT and NAG). Creatinine
clearance was compared to age related normal values. Nine patients
(9.3%) showed creatinine clearances of less than 80%, and 39 patients
(41.5%) had a normal creatinine clearance. In 36 patients (36.1%) a
creatinine celarance of more than 120% (hyperfiltration) was found.
Thirty-three patients (34%) were hypertensive according to WHO-
criteria. In 14 of these the hypertension was known before the unine-
phrectomy. There was no significant correlation between hypertension,
creatinine clearance, age of the patient and duration after uninephrec-
tomy. Between hyperfiltration and hypertension no correlation could be
established. In the hypertensive group a significant (P < 0.001) higher
proteinuna (albumin, transferrin, total protein) was found in compari-
son to the non-hypertensive group. In conclusion: Even years after
uninephrectomy hyperfiltration of the kidney can be found, however,
without substantial affection of kidney function as measured by pro-
teinuria or enzymuria. The occurrence of hypertension seems to be
promoted. The appearance of microproteinuria is more likely a result of
the hypertension as a result of the hypertension.
Excretion of soluble 4SkDa monocyte membrane antigen in patients
with kidney diseases. J.E. Scherberich, J. Schneider, A. Nockher, and
W. Schoeppe, Abteilung Nephrologie Universitats-Klinik Frankfurt!
Main, Germany. Since interstitial infiltrates of monocytes may contrib-
ute to the progression of kidney diseases (interstitial fibrosis, glomeru-
losclerosis), we were interested in studying if whether or not membrane
proteins of monocyte origin are released into urine of patients with
kidney diseases. Screening was performed in aliquots of second mid-
morning random spot urine samples of 16 controls and 55 patients
suffering from primary and secondary renal diseases. Concentrations of
the soluble 48 kDa membrane surface antigen, specific for monocytes,
was assessed applying sandwich ELISA by use of two monoclonal
antibodies capable of recognizing different epitopes of the molecule.
Data were calculated as protein-creatinine-index (PCI; mg.ImMol creat-
mine). As compared to the controls, 26 of the 55 patients disclosed
augmented urine concentrations of the monocyte antigen (2 P < 0.01),
where, in selected cases, the values exceeded five times from that of
normal (0.028 PCI). No correlation was found between serum and urine
concentrations. Clinical signs of active disease phases paralleled in-
crased output of the monocyte protein, followed by decreased levels
during recovery, as revealed through longitudinal monitoring. The
results indicate that soluble monocyte membrane protein might be
excreted in urine of patients with kidney diseases at an increased rate,
and further studies should elucidate if this phenomenon is related with
factors governing progressive kidney injury.
Intravenous cyclophosphamide (CP) pulse therapy for lupus nephri-
tis—duration of induction therapy. D. Schaumann, R. Hem, T. Witte,
R.E. Schmidt, R. Brunkhorst, K.H. Neumann, H. Deicher, and K.M.
Koch, Departments of Nephrology and Immunology, Medizinische
Hochschule Hannover, Germany. I.V. CP pulse therapy has proven to
be superior to other forms of therapy for lupus nephritis concerning
preservation of renal function. To date, however, the duration of
therapy to induce remission of lupus nephritis or stabilization of renal
function has not been established. In this study, SLE patients (ARA
criteria) with renal involvement (nephritic sediment, proteinuria >1.5
g/day) were biopsied and randomly assigned to receive 0.5 to 1 gIm2 iv.
CP qlmo. and low dose steroids for either one year (A) or three months
(B). If in (B) remission could not be acchieved after three months, CP
therapy was continued for another three months. In group (A) all
patients were either in remission or had a stable renal function after one
year. In group (B) there was no remission after only three months of
therapy, but after six months in 3/7 and after 12 months in all 7/7
patients. Up to the present, 13 patients (A+B) completed the one-year
induction phase and were followed for one to 25 months (mean 12.5
months) in remission.
Scr
/2mol/liter
Ccr
mI/mm
u-prot
g/day
aDNA-ab
lU/mi
Pre-treatment 103 41 95 43 4.4 2.0 403 252
Post-treatment 108 66 80 34 0.8 1.4 37 10
N = 13, mean SEM
We conclude that monthly i.v. bolus therapy with CP for 12 months in
combination with low dose steroids induces long lasting remission of
lupus nephritis. Possibly, in some patients a six-month course is
sufficient to induce remission.
Therapy of the membranous glomerulonephritis with nephrotic syn-
drome. A prospective, randomized multi-center study. N. Braun, M.
Przechera, A. Weber, GA. Muller, C. Erley, P. Heering, I. Zäuner, C.
Grupp, R. Funfstuck, H.E. Franz, P. Schollmeyer, B. Grabensee, G.
Stein, and T. Risler, Medical University Hospitals of Tubingen, Diis-
seldorf, Freiburg, Ulm, and Jena, Germany. The therapy of the
idiopathic membranous glomerulonephritis (MGN) is still under discus-
sion. We compared the serum creatinine and 24 hour proteinuria in
patients treated with two different therapy protocols and one control
group at the beginning and after six months. Ninety-two patients were
diagnosed having MGN between 1986 and 1992. Sixty-eight (74%)
patients (30 female, 38 men) completed six months of follow-up. The
mean age was 42 18.9 years in females (I) and 44 13.9 years in men
(m). Among the patients completing the study, 24 (16 f, 8 m) were
treated with prednisone and cyclosporine [deSanto-scheme (5)]. Sev-
enteen patients (3 f, 14 m) were treated according to the Pontichelli-
scheme (P): Pulse-dose-methyiprednisone was followed by steroid
maintenance therapy for six months and chlorambucil for the first 30
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days. Twenty-seven patients (11 f, 16 m) were only treated symptom-
atically (C). There were no significant differences between the three
groups at the beginning of the study. Serum creatinine: P = 1.04 0.28
mg/dl, S = 0.97 0.33 mg/dI, C = 1.03 0.41 mg/dI; proteinuria: S =
8.1 4.7 g, P = 9.5 4.0 g, C = 9.1 9.5 g. We found a significant
decrease in 24 hour proteinuria (P < 0.001 for groups S and P, P < 0.05
for group C) in all patients after six months, while the serum creatinine
remained unchanged: Serum creatinine: 1.59 1.32 mg/dl, S = 1.47
1.22 mgldl, C = 1.30 0.92 mgldl; proteinuria: P = 4.1 3.2 g, S = 4.3
3.9 g, C = 3.8 3.9 g. Conclusion: A specific therapy (deSanto- or
Pontichelli-scheme) of the MGN produces a significant decrease in 24
hour proteinuria, but it is not superior to symptomatic treatment.
Elevated urinary C5b-9 excretion Indicates progression of membranous
nephropathy (MN). M. Schuize, R. Brunkhorst, U. Frei, and K.M.
Koch, Abteilung Nephrologie, Medizinische Hochschule Hannover,
Hannover, Germany. Experimental studies in Heymann nephritis and
studies in patients with membranous nephropathy (MN) suggest that
elevated urinary C5b-9 excretion indicates on-going immune deposit
formation and activity of disease. To determine whether elevated
urinary C5b-9 excretion would serve to identify MN patients with
progressive disease in a clinical setting, we studied urinary C5b-9
excretion of 23 patients with biopsy proven MN with nearly normal
renal function (mean serum creatinine 133 86 mol/liter). The
follow-up time was 18 months (range 5 to 36 months) during which time
an average of eight C5b-9 determinations per year were performed.
Seven patients received no treatment while the other patients received
therapy according to the Ponticelli scheme of three cycles of prednisone
followed by either chorambucil or cyclophosphamide. A positive out-
come was defined as reduction of proteinuria to less than 4 g/day during
the follow-up time, while in a negative outcome proteinuria was not
reduced or remained above 4 glday. Presence of elevated urinary C5b-9
excretion in more than 20% of the measurements per year was signifi-
cantly correlated with a negative outcome (P < 0.01, chi-square test).
Treated patients behaved similarly to untreated patients. These data
suggest that detection of elevated urinary excretion at a low rate upon
repetitive measurement might be sufficient to identify patients with
progressive disease. This phenomenon might be a differential parameter
when the indication to therapy is evaluated.
Hereditary renal cell carcinoma and Von Hippel-Lindau Syndrome.
H.P.H. Neumann, Department of Nephrology, University of Freiburg,
Freiburg, Germany. Hereditary renal cell carcinoma (RCC) is a classi-
cal feature of the Von Hippel-Lindau syndrome (HLS), disorder caused
by an yet unidentified tumor-suppressor gene. In the large Freiburg
HLS study, clinical data, EDTA blood samples, and tumor material
were obtained from 92 carriers out of 29 kindred and unaffected
relatives. Linkage analysis using the polymorphic markers 233El,
233E2, 64E2, 479 H4 and cRAF defined the disorder to the region of
chromosome 3p 25-26. Tumorgenetics of pheochromocytoma and RCC
showed structural alterations on 3p, and loss of heterogenity was seen
in a RCC in HLS. There was a striking tendency for familial clustering
of HLS features in affected kindreds, both angiomatosis retinae and
hemangioblastoma of the CNS occurred in most families whereas renal
lesions and pheochromocytoma were almost mutually exclusive. This
finding suggests that HLS is caused by different mutations within a
complex genetic locus or additional genetic lesions, which cooperate
with the HLS gene. The results were obtained in cooperation with B.
Seizinger, S. Klauck, J. Decker, Boston, and G. Kovacs, Friedrich,
USA.
Analysis of the COL4A5 gene in 20 patients with alport syndrome
disclosed two deletions and one point mutation affecting a splice site. K.
Netzer, L. Renders, 0. Pullig, J. Gobel, U. Frei, K. Tryggvason, and
M. Weber, Medizinische Klinik IV, University Erlangen-Nurnberg;
Department of Nephrology, Med. Hochschule Hannover, Germany;
Biocenter and Department of Biology, University Oulu, Finland. The
COL4A5 gene encoding the a5 chain of type IV collagen has recently
been identified as the disease gene for X-linked Alport syndrome.
Characterization of COL4A5 mutations will improve the understanding
of the molecular basis of the disorder and will possibly enable the
correlation of molecular defects with the heterogeneous Alport pheno-
types. We analyzed genomic DNA of 20 Alport males for deletions and
point mutations. All patients had clinically diagnosed Alport syndrome.
Genomic DNA was obtained from peripheral white blood cells (PBL)
and analyzed by conventional Southern blot and slot blot analysis.
eDNA probes spanned the entire coding region of COL4A5. To detect
point mutations, COL4A5 exons 2 to 15 were PCR amplified from
patient and control DNA using specific primers. The PCR products
were then analyzed for a variant melting behavior by denaturing
gradient gel electrophoresis (DGGE). Exons suspected to contain point
mutations were subjected to direct PCR-based sequencing. Two large
deletions were detected by Southern analysis. In one case, a 34 kb
deletion affecting the 14 most 3' exons of the gene was observed. The
second patient harbored a complete COL4A5 deletion. Slot blot exper-
iments confirmed that the latter occurred as a de novo mutation. By
using DGGE, a point mutation affecting exon 14 (from the 3' end) was
identified in a third Alport patient. Sequence analysis confirmed a G to
C transversion at the 5' splice donor site of intron 13. The effect of this
mutation on mRNA splicing was assessed by the analysis of a5(IV)
eDNA generated by reverse transcription from PBL mRNA. The
eDNA showed skipping of exon 14 with exons 15 and 13 directly joined.
The reading frame was preserved. Clinically, all three affected patients
presented with juvenile type Alport syndrome. In addition, deafness
was present. Ocular lesions were detected only in the patients with
deletions. We conclude: (1) Various distinct mutations of the COL4A5
gene may lead to the Alport phenotype. (2) Deletions of the COL4A5
gene are demonstrable only in about 10% of Alport patients. (3) Point
mutations may be detectable by DGGE. (4) Sensitivity and practicabil-
ity of techniques applied for COL4A5 gene analysis have to be
improved before being used in clinical routine diagnosis.
Collagen type III glomerulopathy: A newly recognized glomerular
disease-entity. An update including a review of the literature until 1992.
E.H. StrØm, E. Imbasciati, G. Gherardi, K. Morozumi, F. Gudat, Rita
Epper, M.J. Mihatsch, Institute of Pathology, University Basel, Basel,
Switzerland; Nephrology Unit and Laboratory of Pathology, Hospital
of Sondrio, Sondrio, Italy. A new type of idiopatic glomerular disease
is reported in a 49-year old Italian woman with hypertension and slight
proteinuria. Familial renal disease, specifically nail-patella syndrome
was clinically excluded. Renal biopsy showed a picture similar to
lobulated membranoproliferative glomerulonephritis, while e.m. dis-
closed mesangial and capillary deposition of granular and fibrillar
material with typical collagen fibers, immunohistochemically identified
as collagen type III. An update of the literature resulted in similar
observations in 16 Japanese patients and one caucasian American
patient. Evidence of systemic disease is lacking, etiology and patho-
genesis are elusive, and a progressive deterioration of renal function
must be expected. Collagen type III glomerulopathy is suggested as
term of this disease.
Target selectivity within the single nephron and early markers of renal
dysfunction following cadmium exposure. L.M. Fels, K. Jung, Monika
Pergande, and H. Stolte, Division of Nephrology, Medical School
Hannover, University Hospital Charité, Humboldt University Berlin,
Berlin, Germany. The aim of the present study was to evaluate the
significance of new markers of nephron integrity that allow localization
alterations in kidney function at an early stage. This study on cadmium
(Cd) exposed subjects exemplifies the approach. Based on urinary
Cd-levels, 172 volunteers were classified as subjects with low, medium
or high exposure (<1.5, 1.5 to 5, >5 g Cd/g creatinine, respectively).
Twenty-seven urinary parameters of kidney function or integrity that
allow a specific localization along the nephron were tested (established
markers, such as: low molecular weight proteins, tubular enzymes; new
markers, such as: brush border antigens, fibronectin, eicosanoids).
High correlations were found between urinary Cd and the total amount
of low molecular weight proteins (LMWs), alanine aminopeptidase,
(weighted correction coefficients r > 0,35, P < 0.001) and urinary Cd
and intestinal alkaline phoshatase (lAP), brush border antigens, throm-
boxane B2 (r> 0.45, P < 0.001). Elevated median values particularly of
markers of the proximal tubule (retinal binding protein, 132- and a1-
microglobulin, lAP) confirmed that this nephron segment is the main
target of Cd. However, glomerular markers like TXB and high molec-
ular weight proteins like transferrin indicate a glomerular involvement.
Markers of the loop of Henle and the distal tubule did not show
significant changes. Prostaglandin F2,, pointed towards effects of Cd on
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the collecting tubule or interstitial cells. The findings allowed the
development of a model of discriminant analysis based on selected new
and established parameters. It is concluded that new markers, particu-
larly eicosanoids, brush border antigens and lAP, can be valuable tools
to detect Cd exposure and to localize early renal dysfunction.
Ochratoxin A blocks CL— channels: Is this action responsible for its
nephrotoxicity? M. Gekle, H. Oberleithner, and S. Silbernagl, with
technical assistance of S. Mildenberger and R. Freudinger, Depart-
ment of Physiology, University of Wurzburg, Würzburg, Germany.
Ochratoxin A (OTA) is a widespread nephrotoxin and has been sus-
pected of causing Balkan endemic nephropathy. Although most findings
point to the glomerulus and the proximal tubulus as the intrarenal target
sites, some results reported also point at postproximal sites. Our initial
clearance experiments showed that subchronic application of OTA
resulted in an increased fractional water excretion and an increased
dependence of the osmolal clearance on urine flow. These data confirm
the hypothesis that OTA affects postproximal sites in the kidney.
Methods: We investigated the acute effect of OTA in vivo (1.2 mglkg
i.v., male wistar rats) on urinary pH, Na-excretion and titrable acid
(TA). The effects of OTA on MDCK cells (originating from the
collecting duct) were investigated in vitro. Results: (for all P <0.05;
SEM, N = 7) (1) OTA increases urinary pH from 6.0 0.2 to 6.6 0.1
and urinary sodium excretion from 1.58 0.28 to 2.53 0.27 nmol/
min/100 g body wt. At the same time, TA decreased from 0.29 0.03 to
0.12 0.04 mol/min/l00 g body wt. Superfusion of MDCK cells (N =
5) with OTA (I smol/liter) reduces the fractional Cl conductance to 9
6% of control. Evaluation of the dose-response curve resulted in an
IC50 value of 30 5 nmol/liter. Conclusions: (1) OTA is a potent Cl
channel blocker. (2) The blockage of C1 channels in the collecting duct
(and in the thick ascending limb?) reduces the C1-permeability-coupled
proton secretion and reduces sodium reabsorption.
Contrast media-induced renal failure—Prevention by theophylline?
Christiane M. Erley, S.H. Duda, S. Schlepckow, J. Koehier, P.E.
Huppert, H. Osswald, T. Risler, Departments of Internal Medicine,
Department of Diagnostic Radiology, Institute of Pharmacology, Uni-
versity of Tubingen, Germany. Radiographic contrast media (CM) can
induce renal failure, and this may serve as an experimental model of an
acute renal failure (ARF). One vasoactive factor likely to be involved in
ARF is adenosine. In a double-blind placebo controlled study, we
investigated the effect of theophylline (TP), a direct adenosine antago-
nist, regarding changes in renal hemodynamics induced by CM. Thirty-
five patients (group 1 + 2: GFR >75 mI/mm, group 3 + 4: GFR <75
mI/mm) who received 100 ml of a nonionic low osmolar CM (iopromide)
were investigated for changes in GFR and RPF [before (1) and after (2)
three hours of CM application] by continuous inulin and PAH clear-
ance. Forty-five minutes before application of CM they received either
TP (5 mg/kg body wt) or saline.
mI/mm
Group 1(N=ll)
9 TP
Group 2(N=8)
9 TP
Group 3(N=8)
9 TP
Group 4(N=8)
9 TP
GFR 1 113 33 98 14 59 13 62 16
GFR 2 92 27 105 21 53 16 65 18
RPF 1 584 100 458 213 300 117 306 103
RPF2 500 98 465 172 312 116 296 57
a P < 0.05 compared to baseline.
Reduction of GFR can be prevented by infusion of TP in case of CM
application in patients with and without renal function impairment. This
indicates that adenosine might play a major role in CM-induced ARF.
Urinary excretion of renal tubular cell proteins after cisplatinum
therapy. H.-W. Birk, Heike Schoepe, W. Schroyens, H. Koepsell, and
G. Schütterle, Medizinische Klinik II der Justus-Liebig-Universitat
Giejlen, and Max-Planck-Institut für Biophysik Frankfurt/Main, Ger-
many. In order to further characterize tubular toxicity of dichlorodiam-
mine-cisplatinum, urinary excretion of marker proteins from defined
nephron segments was investigated. Monoclonal antibodies directed
against tubular proteins from different subcellular localizations (luminal
membrane, intermicrovillar domain, cytoskeleton, nuclear membrane)
were employed for urine analysis by radioimmunoassay. Urinary pro-
teins were immobilized on a solid phase, reacted simultaneously with
different monoclonal antibodies, and detected with a cascade of spe-
cies-specific antisera. Twenty-four hour urine specimen from eight
patients under cisplatmnum therapy (20 to 36 mg/m2/day, for 5 days)
and hyperhydration were studied. All patients had normal kidney
function before treatment. The daily excretion of marker proteins from
the proximal brush-border, from distal tubular cells, and from nuclear
membrane increased up to maximally eightfold during treatment as
compared to pretherapeutic values. This proves injury of both, proxi-
mal and distal tubular cells, and indicates the occurrence of an
increased number of cell necroses. Analysis of urinary excretion of
tubular cell proteins allows sensitive monitoring of toxic tubular injury
during cisplatinum therapy and might be helpful for the assessment of
protective regimens and toxicity of new platinum analogues.
Effects of low-calcium (L-CA) dialysate on peritoneal-macrophage(PMØ) functions. T. Kiefer, U. Schenk, E. Hübel, J. Weber, Jutta
PaJilick-Deetjen, and U. Kuhlmann, Robert-Bosch-Hospital, Depart-
ment of Nephrology, Stuttgart and Fresenius AG Oberursel, Germany.
Pentoneal dialysis solutions with a 1-ca concentration (1.00 mmol/liter)
could prevent hypercalcemic episodes, especially in patients treated
with calcium containing phosphate-binders and Vitamin-D3. Divalent
cations play a role in immunological functions of phagocytic cells. The
aim of our study was to find out if a 1-ca dialysate suppresses
PMØ-functions stronger than dialysates with higher ca-concentrations.
The influence of different ca-solutions on PMØ-functions was exam-
ined. Methods: After isolating PMØ of 10 CAPD patients the cells were
incubated (30 minutes, 37"C) in Hanks buffered Salt Solution (HBSS,
0.0,0.5, 1.0, 2.0, 3.0, 5.0 mmol Ca/liter) and in three otherwise identical
dialysis solutions (1.0, 1.45, 1.75 mmol Ca/liter). We performed the
following tests: (1) killing assay for Staph. epidermidis; (2) phagocytosis
assay for Staph. epidermidis; (3) superoxide production by cyto-
chrome-C (Cyt.-c) reduction after phorbol myristate acetate (PMA)
stimulation: (4) luminol and lucigenin enhanced chemiluminescence
(CL) after PMA stimulation. Results: PMØ functions were significantly
suppressed after incubation in calcium free HBSS compared to calcium
containing HBSS: killing: (31.6* vs. 42.9%); phagocytosis: (l8.8# vs.
21.4%); CL: [Luminol: 405.8" vs. 600.4; Luzigenin: 4473* vs. 650.3
(integral cpm x lOiiO cells]; superoxide production (12.0" vs. 14.2
nmol Cyt.-C reduction/b4 cells); (Wilcoxon's rank sum test *: P <
0.01; #: P < 0.05). There was no significant dose dependent change in
PMØ function between 0.5 mmol/liter and 5 mmol/liter Calcium (P>
0.05 Friedman-Test). After incubation in the dialysates the following
results were found (mean SD):
Calcium/liter Killing
CL CL
luminol lucigenin
integral cpm x JO4/104
Superoxide
nmol Cyt.-C
Reduction/JO'
dialysate % cells cells
1.00 mmol 41.1 8.6 243.2 98 676.8 180 9.6 2
ph 7.4
1.75 mmol 43.5 8.3 262.6 t02 705.1 185 9.7 1.7
ph 7.4
The results were not significantly different (P> 0.05 Wilcoxon's rank
sum test).
Conclusion: According to our in vitro results the use of I-ca dialysate
would not impair PMØ-functions. Only a complete depletion of extra-
cellular calcium was followed by a significant suppression of PMØ-
functions.
Effect of different peritoneal dialysis solutions on the function of human
peritoneal macrophages (PMO) in vitro. M. Andre, Birgit Egle, Ritva
Atmanspacher, P. Schollmeyer, Iris Lubrich-Birkner, and H.B. Stein-
hauer, Department of Internal Medicine, Division of Nephrology,
University of Freiburg, Freiburg, Germany. In spite of technical
improvements in continuous ambulatory peritoneal dialysis (CAPD),
bacterial peritonitis remains a main complication. This supposedly
partly due to an impaired local cellular defense induced by peritoneal
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dialysis solutions. The aim of the present study was to investigate the
effect of various peritoneal dialysis(PD) fluids on the release of cyto-
kines and eicosanoids from PMO and on their phagocytic activity in
vitro. PMO were isolated from fresh PD effluent by density gradient
centrifugation over Ficoll-Hypaque. After preincubation in RPMI 1640
(2 hr) the adherent cells (>95 PMO) were incubated for 18 hours in
various PD solutions [A: Glucose 1.36%, B: Glucose 3.86%, C: Amino
acids 1%, D: Bicarbonate(BIC) 27 mmollliter, E: BIC 35 mmoL'liter].
RPMI 1640 served as control medium(CM). The concentrations of
eicosanoids (PGE2, TXB2, LTB4, LTC4) and cytokines (11-6, TNF) in
medium were measured by RIA or ELISA. The phagocytic activity was
determined after 30 minutes of incubation with zymosan (100 particles!
PMO) and the PD fluids A through E and CM by counting the ingesting
cells. The standard PD solutions (A,B) suppressed the release of all
investigated mediators by >80% in comparison with CM. The inhibi-
tory effect of PD fluid C on prostanoid generation was less pronounced
[PGE2:38.2 23.6% ( SD, N =5), TXB2:68.8 17.0%]. The lowest
suppressive effect on the release of mediator substances by PMO was
observed with PD fluid D in which lactate (35 mmol/liter) is exchanged
by bicarbonate (27 mmol/liter), The phagocytic activity of PMO corre-
lated positively with the release of eicosanoids and cytokines. The
present data indicate that the PD solutions containing amino acids and
bicarbonate exert more minor inhibitory activity on human PMO than
the glucose- and lactate-based PD solutions used at time, and may
improve the local cellular defense during CAPD.
Are ANP, CGMP or vena cava diameters suitable parameters to
estimate dry weight in dialysis patients? J. Plum, M. Lübbe, and B.
Grabensee, Department of Nephrology, Heinrich Heine University,
Düsseldorf, Germany. Up to now sensitive indicators are missing to
define and to monitor the so-called "dry weight" in dialysis patients.
We studied the diagnostic value of plasma concentrations of atrial
natriuretic peptide (ANP), cyclic GMP (both measured by RIA) and
vena cava diameter (VCD, controlled by sonography) in a long-term
study over six months in 15 HD patients and 15 CAPD patients.
According to their cardiac status (chest x-ray, echocardiogram) the
patients were divided into four groups. Group A: eight HD patients
without heart failure (ultraffitration 2.4 1.31); Group B: seven HD
patients with heart failure (NYHA 11-Ill, ultrafiltration 2.5 0.81);
Group C: nine CAPD patients without heart failure; Group D: six
CAPD patients with heart failure (NYHA Il-Ill). The highest ANP
levels were found in Group D (543 398 pg/mI), followed by Group B
(380 135 pg/mi), Group A (183 77 pg/mI) and Group C (169 57
pg/ml),(normal 62 27 pg/mI). ANP and cGMP levels proved to be
remarkably stable in CAPD patients and showed cyclic interdialytic
changes in HD patients. The correlation between the predialysis
difference of clinically estimated dry weight and the corresponding
predialysis ANP levels was r = 0.56; for VCD it was r = 0.46. The VCD
closely correlated in HD patients with ANP levels r = 0.73; the same
was valid in CAPD patients, r = 0.74. In a special trial six HD patients
were brought to three different weight levels (difference from dry weight
+0.5, —0.5 kg) in three consecutive HD treatments. Using these
well defined conditions we found a high correlation (r 0.87) between
ANP levels and the actual difference from dry weight. In contrast to
ANP, plasma cGMP concentrations decreased by isovolemic HD and
were of minor predictive value. The results indicate that plasma ANP
and, with minor sensitivity, VCD represent additional clinical tools to
control dry weight in HD and CAPD patients.
Impaired function of platelet fibrinogen receptor (GPIIb-Illa) in pa-
tients with end-stage renal failure (ESRF). M.P. Gawaz and H.-.!.
Gurland, Department of Nephrology, Klinikum GroJ3hadern, Univer-
sity of Munich, Munich, Germany. The platelet fibrinogen receptor
GPIIb-IIIa plays a crucial role in platelet aggregation and primary
haemostasis. We studied GPIIb-IIIa function in platelets of 10 patients
with end-stage renal failure who were treated regularly by hemodialysis
and of seven healthy volunteers. Platelets were stimulated with ADP or
phorbol ester (PMA) and the functional state of GPIIb-IIIa was deter-
mined by use of conformation-dependent monoclonal antibodies (anti-
LIBSI, PMI1) and flow cytometry. Ligand binding was evaluated in
peptide GRGDSP dose-response curves. ESRF patients showed a
reduced ADP- or PMA—induced activation of GPIIb-IIIa compared to
the control group. GRGDSP dose-response curves exhibited markedly
reduced GPHb-IIIa peptide binding. This was not due to modification of
the molecular structure or glycosilation of GPIIb-IIIa, since anti-GPIIb-
lila immunoblot and PAS-staining patterns were not found to be
different in both groups. In conclusion, the present data show that
GPIIb-IIIa receptor function is impaired in patients with end-stage renal
failure, most likely due to a ligand binding defect. Impaired platelet
fibrinogen receptor function which causes dysfunction of platelet ag-
gregation may play an important pathophysiological role in uremie
bleeding tendency.
Noninvasive measurements of vessel wall properties in normotensive
chronic hemodialysis patients depending on age. Volker Laske, Peter
Baum gart, Michael Barenbrock, Stefan Heidenreich, Helge Hohage,
Walter Zidek, and Karl Heiz Rahn, Medizinische Poliklinik, Universität
Munster, Germany. Chronic renal failure is frequently associated with
hypertension. However, during chronic hemodialysis blood pressure
often decreases to normal values. In this study the vessel wall proper-
ties of normotensive hemodialysis patients (HD) in comparison with
normotensive healthy volunteers (N) were investigated depending of
age. Twenty-four HD and 24 N were included. Both HD and N were
devided in respect of age into two groups (HD1: 36.3 2.0 yr; HD2:
60.2 2.3 yr; Ni: 36.8 2.5 yr; N2: 58.2 1,6 yr). In all subjects the
local elastic properties of common carotid artery were investigated
noninvasively using a multigate pulsed Doppler system. Concomitantly,
the blood pressure was obtained by continuous noninvasive finger
blood pressure recording via the Finapres' device. In HDI a lower
distensibility (DC: 18.8 1 7* 103/kPa) and an increased enddiastolic
diameter (d: 7.3 0.3 mm) in comparison with Ni (DC: 25.0
1.9*lO_3/kPa), P < 0.05; d:6.3 0.3 mm; P < 0.05) were measured.
However, these differences were not significant between HD2 (DC:
11.7 1.l*103/kPa; d: 7.8 0.3 mm) and N2 (DC: 12.8 1.6*103/
kPa; d: 7.2 0.3 mm). The results demonstrate that the distensibility of
the common carotid artery in younger hemodialysis patients is reduced
and the vessel diameter is increased in comparison with age matched
controls. These differences diminish with age due to normal age-
dependent decrease of vessel wall distensibility.
Risk factors and survival rates in diabetics undergoing hemodialy.
sic—A prospective study. M. Koch, B. Thomas, W. Tschöpe, and E.
Ritz, Departement of Nephrology, University Heidelberg, Heidelberg,
Germany. The high cardiovascular mortality in uremic diabetic patients
is well-known, The aim of this prospective study was to evaluate
predictors of cardiovascular mortality. Between 1985 to 1987 we
examined in 28 dialysis centers in Germany all diabetics starting dialysis
treatment and followed them up for 45 months: 196 patients, 67 type I
[43 men, 24 female, median age 49 years (22—73)] and 129 type II [43
men, 24 female, median age 64 (37—82)]. After 45 months 47% of all
diabetics were dead (43% of type land 50% of type II; 43% of men, 45%
of women). Sixty-two percent of deaths were of cardiovascular causes
due to myoeardial infarction (19%), sudden death (19%), and other
cardial reasons (19%); Stroke (5%), non-cardiovascular reasons (38%).
Predictors of cardiovascular mortality were: sex [14/20 (70%) patients
with infarction were men], age (median age of patients dying from
cardiovascular causes 62.5 years), serum-cholesterol (myocardial in-
farction 258 mg/dl, survivors 222 mg/dl). History of myocardial infarc-
tion or angina pectoris was more frequent in patients dying from
cardiovascular causes than in patients dying from non-cardiovascular
causes (history of MI 37% vs. 21%; history of AP 65% vs. 34%).
Proliferative retinopathy was more frequent in patients dying from
cardiovascular causes (58% vs. 27%). Hypertension with a high prev-
alence of 98% and duration of hypertension, septum thickness and
sokolov index seem to have no predictive effect. Conclusion: Type I
diabetics have the same survival as the 15 year-older type II diabetics.
Predictors of cardiovascular mortality were sex, age, serum-cholesterol
and history of vascular complications.
Multi-center study of the prevalence of ANCA-positive vasculitis upon
dialysis. Stefanie Weidemann, K. Andrassy, and E. Ritz, Medizinische
Universitats-Klinik, Heidelberg, Germany. The prevalence of vasculit-
ides (V) upon dialysis in Germany is given as 0.5% (EDTA statistics).
This is in contrast to the frequency of more than 2% in France and
England. With the ANCA tests ANCA-IF (C- and P-ANCA), ELISA
for proteinase 3-ab (PR 3), myeloperoxidase-ab (MPO), lactoferrin-ab
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(LF), and elastase-ab (EL), methods are available for reliably diagnos-
ing Wegener's granulomatosis (WG) and microscopic polyarteritis(MPA), the V most relevant for nephrologists. It was the aim of this
investigation to determine the prevalence of ANCA-pos.V in 1.277
patients from 16 hemodialysis centers. RESULTS: C-ANCA (IF, me-
dian 1:20, range 1:20—320) was detected in 32/1.277 patients: 7/32 were
PR 3-ab pos., 2/32 had MPO-ab, 2/32 LF-ab and 3/32 EL-ab. P-ANCA
(IF) (median 1:80, range 1:20—1:280) was found in 65/1.277 patients:
20/65 were MPO-ab pos., 0/65 had PR-3-ab, 1/65 LF-ab and 15/65
EL-ab. The high number of EL antibodies was striking; degranulation
of neutrophils through membrane contact repeated bacterial infection
might be responsible. Four patients with pos. C- or P-ANCA(false pos.
ANCA) had an amyloidosis (RA); 5/97 patients with pos. ANCA had a
RPGN without symptoms of an extra-renal systemic disease. In addi-
tion to the seven known cases of WG/MPA, 17 hemodialysis patients
with WG/MPA were re-diagnosed. Low titer-ANCA (IF 1:20—40) with-
out detection of antibodies in ELISA was not associated with symp-
toms of systemic disease and can possibly be attributed to the known
proneness of dialysis patients to develop auto-immune antibodies.
Summary: Through ANCA, a respectable number of undetected cases
of systemic disease in the hemodialysis population can be exposed. The
combination of ANCA (IF) and ELISA allows a reliable diagnosis of
WG/MP even in patients on hemodialysis.
Severe secondary hyperparathyroidism (HPT). Oral calcitriol pulse
therapy depending on body weight. H. U. Klehr, D. Hristea, B. Klein, D.
Paar, and U. Jacobs, Department of Internal Medicine, University of
Bonn, Bonn, Germany. The daily oral calcitriol therapy is often
insufficient to control the severe HPT in hemodialysis(hd) patients. The
intermittent intravenous or oral pulse therapy have been proposed but
are riddled by the risk of hypercalcemia. Therefore, we had the idea of
giving an oral calcitriol pulse therapy depending on body weight. In a
pilot study we treated six patients with clinical signs of HPT and iPTH
levels of 42 to 147 pmol/liter (norm 1.0—5.1 pmol/liter) with an oral dose
of 0.05 rg calcitriol/kg body wt three times a week. Oral calcium
therapy was terminated and hemodialysis calcium concentration of 1.75
mmol/liter was continued. Already during the first four weeks of
therapy the iPTH levels were falling to half of the initial amount.
Hypercalcemia of 3 mmol/liter occurred only in one case for only one
week. An evident decrease of the alkaline phosphatase or the osteocal-
cm as markers of bone metabolism in the first three months was
observed. In conclusion, the oral calcitriol pulse therapy depending on
body weight is very effective and safe in the treatment of patients with
very high iPTH levels.
Moderate secondary hyperparathyreoidism prevents bone loss in long.
term hemodialysis patients treated for more than 10 years—Histomor.
phometry of 56 cases. B. Hinrichs and G. Delling, Division of Bone
Pathology, University of Hamburg, Hamburg, Germany. Renal os-
teodystrophy as seen in patients under treatment with long-term dialy-
sis exceeding 10 years shows a heterogeneous morphology. Up to now
it still remains unclear whether osteopenia occurs and which conditions
lead to bone loss. A possible interaction of diminishing bone volume
with cellular turnover has only been studied in small numbers so far. To
evaluate structural and cellular changes of bone we investigated 56
undecalcified iliac crest biopsies of patients with more than 10 years
(160 31 months) of maintenance dialysis by computerized interactive
morphometry. Aluminum was detected histochemically. Morphometric
data were correlated with age and sex matched healthy subjects (N =
238 for BY/TV and N = 74 for static bone parameters) as well as with
a group under short-term (18.4 20 month) dialysis (N = 306). Results:
Trabecular bone volume is significantly (P < 0.05) lower in long-term
dialysis than in short-term dialysis. However, patients with more than
10 years of hemodialysis do not have a lower bone volume than healthy
subjects. Especially patients with endosteal fibrosis, measured as
fibrosis volume (FbV/TV), which con-elates (P < 0.0001) with bone
turnover, have normal or higher By/TV (P < 0.01). As others demon-
strated we found a high percentage of aluminum in endosteal surfaces
(48%). Aluminum was also found with an inverse correlation (P < 0.01)
in those cases with endosteal fibrosis and especially in aplastic renal
bone disorder. We conclude that patients with long-term dialysis should
have a mild or moderate hyperparathyroidism to prevent bone loss.
Synergistic effect of citrate and renal failure on the intestinal absorption
of aluminum. T.H. Ittel, U. Gladziwa, R. Böhm, and H.G. Sieberth,
Internal Medicine II, RWTH, Aachen, Germany. Clinical and experi-
mental data suggest that citrate as well as renal failure enhance the
intestinal absorption of aluminum (Al). The present study investigated
whether both factors may have a synergistic effect on the incorporation
of Al in patients with chronic renal failure [CRF] (median creatinine
clearance: 24[16.—41J mI/mm/I .73 m2; N = 13)and in control subjects [C](N = 14). Following an oral load of 1100 mg Al [Al(OH)3] together with
4.9 g citric acid serum concentrations of Al, intact PTH and osteocalcin,
and urinary excretion rates of Al were measured over 96 hours.
Baseline excretion of Al was similar in both groups (C: 6 1 ,ug/day,
CRF: 5 3 pg/day). Following administration of Al urinary excretion
rates of Al rose within four hours (C: 414 65 sg/4 hr, CRF: 451 88
sg/4 hr) and maximum excretion rates were observed after eight hours
and 12 hours in C (484 74 jsg/4 hr) and CRF (660 224 gg/4 hr),
respectively. In parallel, there was a marked increase in serum Al
within 60 minutes (C: 62.5 9.6 sg/liter vs CRF: 238.6 51.3 gIliter,
P < 0.0025) and maximum concentrations were attained after two
hours. Serum Al was higher in the CRF group at any time. After 12
hours, urinary excretion rates of Al were consistently higher in the CRF
group and post-load total excretion was I .8-fold larger as compared to
C (4088 483 sg vs. 2290 282 tg, P < 0.005) suggesting enhanced
absorption in renal failure. In the CRF group PTH was elevated six and
10 hours after administration of Al (170 40 pg/mI vs. baseline 112
25 pg/mI, P < 0.01) and, consecutively, serum osteocalcin rose from 23
4 ng/ml to 29 6 ng/ml after 72 hours (P < 0.05). In conclusion: (1)
Chronic renal failure further augments the enhanced intestinal absorp-
tion of aluminum in the presence of citrate. (2) Despite large increases
in serum aluminum there may be a transient stimulation of PTH
secretion and osteoblast activity following combined administration of
citrate and aluminum.
Cytosolic free sodium in mild chronic renal failure. Novel studies using
the fluorescent dye technique and a linked-enzyme Na-K-ATPase assay.
M. Tepel, S. Bauer, K.H. Rahn, and W. Zidek, Med. Universitäts-
Poliklinik, University of Münster, Münster, Germany. In advanced
renal failure and in patients on hemodialysis an increased intracellular
sodium concentration had been demonstrated in erythrocytes after
hemolysis. With the novel fluorescent dye sodium-binding-benzofuran-
isophthalate (SBFI), cytosolic free sodium concentration ([Na]1) was
measured in intact platelets from 19 patients with mild chronic renal
failure (CRF, 12 men, 7 women, mean age 49 4 yr, mean 5EM,
serum creatinine 2.4 0.4 mg/dl) and 33 age-matched healthy control
subjects (CS, 20 men, 13 women, mean age 46 3 yr, serum creatinine
0.8 0.0 mg/dl). Resting [Na}1 was significantly higher in platelets
from CRF compared to CS (40.8 3.1 m vs. 32.2 2.0 mM, P <
0.05). Inhibition of Na-K-ATPase by 1 mat ouabain significantly in-
creased [Na]1 in platelets from CRF to 93.2 10.0 mat (P < 0.01
compared to resting value) and in platelets from CS to 60.5 5.6 m,
P < 0.01). After ouabain [Na]1 was significantly higher in platelets
from CRF compared to CS (P < 0.01). There was a significant
correlation between resting [Na]1 and [Na] after ouabain in platelets(r = 0.557;P < 0.0002), indicating that regulation of Na-K-ATPase is of
critical importance to maintain intracellular sodium homeostasis. Using
a linked-enzyme Na-K-ATPase assay plasma from CRF produced a
significant inhibition of steady state Na-K-ATPase activity by 11.2
3.0% (P < 0.01). These measurements using the novel fluorescent dye
technique in intact cells showed that also in mild chronic renal failure
sodium transport is impaired, resulting in increased [Na}.
Isolation of a granulocyte inhibitory protein from ultrafiltrate of
hemodialysis (HD) patients—Evidence for beta2 microglobulin fragment.
Marianne Haag- Weber, Brigitte Mai, and W.H. HOrl, Med. Universi-
tãts Klinik Homburg/Saar, Department of Nephrology, Germany.
Increased incidence of infection in uremic patients is mainly caused by
granulocyte (PMNL) dysfunction. Recently, we isolated a granulocyte
inhibitory protein (GIP) from ultrafiltrate of HD patients, which inhibits
four fundamental PMNL-function. We now report on the isolation of a
further PMNL inhibitory protein from ultrafiltrate of HD patients by ion
exchange chromatography and gel filtration. The protein has a molec-
ular weight of 9,500 D and is heat stable. The NH2 terminal amino acid
analysis revealed a complete homology with beta2 microglobulin. The
254 Abstracts
protein inhibits glucose uptake and 02 production of PMNLs stimulated
with the proteinkinase C stimulator PMA (phorbol-myristatrate ace-
tate). There is, however, no inhibitory effect by stimulation with the
chemotactic peptides FMLP and C5a. In contrast, GIP only inhibits
FMLP-stimulated and not PMA-stimulated PMNL functions. We could
isolate a further PMNL inhibitory protein from ultrafiltrate of HD
patients with a different mode of action compared to the first isolated
protein. This protein is a beta2 microglobulin fragment, which differs
from the intact beta2 microglobulin in the molecular weight and obvi-
ously in the C-terminal end. These data confirm the hypothesis that
circulating plasma factors play an important role for PMNL dysfunction
in uremia.
Studies on granulocyte (PMNL) activation during hemodialysis (HD)
with stress on intracellular signals: Comparison of cuprophane, he-
mophane and polyamide. Marianne Haag-Weber, Brigitte Mai, R.
Deppisch, H. Göhl, and W.H. Hörl, Med. Universitäts Klinik Homburg!
Saar, and Gambro Dialysatoren KG Hechingen, Germany. The pur-
pose of the study was to investigate PMNL activation during HD,
putting the main emphasis on the second messengers intracellular
calcium (Ca12) and inositol-tnphosphate (1P3). Six HD patients were
dialyzed in a cross over study for at least six weeks with cuprophane
(CU), hemophane (HE) and polyamide (PA). During HD blood samples
were taken from the arterial line before HD, 15, 30, 60, 120 and 180
minutes after start of HD for determination of lactoferrin, C3a and
terminal complement complex (TCC). Before and after 30 minutes of
HD PMNL5 were isolated for measuring resting and FMLP-stimulated
Ca2 and 1P3. Both HD with CU and HE lead to a significant increase
of C3a and TCC, whereas the anaphylatoxin production during HD with
CU was significantly higher compared to HE. HD with PA had almost
no effct on C3a and TCC. Lactoferrin release during HD with CU was
significantly higher compared to HE and PA (683 151 vs. 439 90 vs.
403 90 ng/ml). Resting Ca12 was significantly elevated before HD
using CU and slightly using HE compared to PA (76 11 vs. 62 8 vs.
48 10 nmol/106 PMNLs). 1P3 was comparable with all membranes
both before and during HD. Our data indicate that calcium is an
important signal for PMNL degranulation during HD. This increase of
Ca12, however is not associated with changes of intracellular 1P3 levels
and stuggests a release of Ca2 from the mitochondrial Ca2 pool and
not from the 1P3 responsive pool.
The IL-6 production in terminal renal insufficiency is pretranscription-
ally down-regulated. G. Leimenstoll, T. Hundhausen, R. Laus, A.
Mogadus, D. Preusse, W. Niedermayer, and W. Mflhler-Ruchholtz,
Department of Nephrology and Institute of Immunology, University of
Kiel, Germany. One reason of immunodeficiency in uremic patients is a
disturbed function of monocytes. Diminished secretion of 11-1 and 11-6
in terminal renal insufficiency has been described. To elucidate at which
stage the 11-6 secretion is affected, we have analyzed IL-6 mRNA
synthesis and various surface epitopes of monocytes in ten dialytic
patients compared to age- and sex-matched healthy controls. Sponta-
neous 11-6 mRNA synthesis of adherence-enriched monocytes was
semiquantitatively determined by rtPCR with /3-actin as internal con-
trol. Analysis of CD 14 (receptor of a LPS/protein-complex), CDI6 (FcR
I) and CD64 (FcR III) was performed by FACS on fibronectin-isolated
monocytes. No differences were found in the expression of CDI6 and
CD64. In contrast, eight of ten dialytic patients revealed a clear cut
reduction of IL-6 mRNA. Also, the percentage of CD14-positive
monocytes was decreased significantly (P = 0.0007). These results
clearly demonstrate that the perturbation of IL-6 production in dialytic
patients is pretranscriptional, possibly mediated by a down-regulation
of CD14 expression on monocytes,
Cyclosporin A (CsA) and acute dialysis-dependent renal failure (ADRF)
in orthotopic liver transplantation (OLT). Claudia Pundrich, D. Kampf,
N. Schattenfroh, M. Wiens, G.M. GahI, and P. Neuhaus, Nephrolo-
gische Abteilung and Chirurgische Klinik, UK Rudolf Virchow, Freie
Universität Berlin, Berlin, Germany. CsA toxicity is considered a major
cause of acute renal failure after OLT. Mostly this is characterized by
a moderate loss of renal function which can be reversed by dose
reduction. The aim of the study was to determine the role of CsA in the
development of ADRF after OLT. From September 1988 to April 1992,
264 OLTs were performed in 248 patients, of which 187 were treated
with a quadruple therapy consisting of CsA, prednisolone, azathioprine
and ATG/BT 563. Within 3.8 1.2 days (mean SEM) post-OLT 21
(11.2%) patients developed ADRF requiring dialysis treatment for 26.5
4.3 days. Only seven of these patients were treated with CsA for 5.1
1.8 days prior to the beginning of ADRF, resulting in a whole blood
level of 661 113 ng/ml (polyclonal RIA). There was no significant
difference between the CsA-levels before, during and after the ADRF
(Wilcoxon-test, P> 0.05). As well as there were no differences between
the CsA levels of patients with ADRF and those of a control group
without ADRF (U-test, P> 0.05). Acute hepatic or transplant failure
(12) were the leading causes of ADRF followed by ischemic renal failure
(5), sepsis (2), and CsA toxicity (2). Only 1 patient died during ADRF.
The presented data show that the most important causes of an ADRF
within four weeks after OLT are acute hepatic or transplant failure. The
two patients with CsA toxicity suffered from chronic renal failure
before OLT. For the development of acute dialysisdependent renal
failure, therefore, CsA might play only an additional role in some cases.
Is it possible to reduce cyclosporine-induced nephrotoxicity by a
magnesium enriched diet? P.M. Rob, K. St. Maas, and D. Sack,
University of Lii beck, Germany. We investigated the influence of diets
with different magnesium (MG) concentrations upon creatinine clear-
ances over a period of 24 days in rats which were given cyclosporine.
Two groups (A,B) did not receive cyclosporine but received 0.5 mI/day
olive oil orally. Group A (N = 8) was given a diet with a normal amount
of MG (1000 ppm), group B (N = 9) was given a MG depleted diet (100
ppm). The other groups were treated with cyclosporine 20 mg/kg/day in
0.5 ml olive oil orally. N = 12 (group C) were given a diet with 100 ppm
MG, N = 9 (group D) 1000 ppm M Gand N = 12 (group E) 10000 ppm
MG. Access to water was free. For creatine measurement urine was
collected at day 0 and day 24, and blood samples were taken by heart
puncture to calculate creatinine clearances. There was no change in
creatinine clearances in group A and B. In group C (2 0.8 vs. 0.8
0.14 mI/mm) and group D (3.9 0.5 vs. 1.6 0.5 ml/min) there was a
significant decrease in renal function (P < 0.05; one dimensional
variance analysis). But there was no significant decrease in creatinine
clearance in group B (1.9 0.5 vs. 1.6 0.5 mI/mm). A dietary lack of
MG, which is often aggravated by cyclosporine treatment because of
tubular loss, could aggravate cyclosporine-induced renal dysfunction.
We have shown that a MG rich diet is able to prevent the decrease of
renal function during a 24 day treatment with cyclosporine.
CsA activates Na!H-antiport and augments proliferation of VSMC.
K-P. Spies, V. Wenzlaff, A. Distler, and H. Hailer, Department of
Internal Medicine, Klinikum Steglitz, Freie Universität Berlin, Berlin,
Germany. An important side effect of therapy with cyclosporin A (CsA)
is accelerated atherosclerosis. As proliferation of vascular smooth
muscle cells is associated with activation of the Na/H antiport, we
investigated whether CsA: (1) influences proliferation, and (2) activates
the Na/H antiport in VSMC. We used primary cultures of VSMC from
rat aorta (passage 1-4). Cell proliferation was measured by thymidine
incorporation and cell count. Intracellular pH (pHi) was assessed in cell
suspension using the fluorescent dye BCECF-AM. Na/H antiport
activity was determined by the initial rate of recovery from acidification
(propionic acid). Incubation with cremaphore was used as control.
Incubation of VSMC with CsA (100 ng/ml, 15 mm) did not influence
basal rate of proliferation of VSMC, but significantly increased serum-
(10% FCS), PDGF- and vasopressin-induced VSMC proliferation by
20%. pHi increased during incubation with CsA (7.24 0.04 to 7.41
0.06, P < 0.05). Basal activity of the Na/H antiport was also increased
by CsA(9.3 0.5 to 15.3 1.7 dH+ x sec' x H+'; P <0.02). CsA
augmented the vasopressin-induced activation of the antiport by a shift
of the setpoint (7.29 0.07 to 7.45 0.06; P < 0.05). Our findings
demonstrate that CsA augments VSMC proliferation and suggest that
CsA-induced activation of the Na/H-antiport is involved. CsA-induced
proliferation of VSMC may play a role in CsA-associated atheroscle-
rosis.
Effect of cyclosporin A (CSA) on proteolytic enzymes in renal cortex:
Experimental and clinical results. M. Steinker, C.J. Olbricht, J. Haas,
W. Auch-Schwenk, C. Bossaller, and KM. Koch, Department of
Nephrology and Neurology, Medical School Hannover, and German
Heart Institute Berlin, Germany. CSA changes the morphology of
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lysosomes in the proximal tubule. A central function of lysosomes is
degradation of cell proteins. The lysosomal proteases Cathepsin B and
L (CAT) are marker enzymes of lysosomal protein degradation. We
measured CAT by fluorescent microassay in kidney cortex, urine and
serum of rats (N = 7) treated by CSA (30 mg/kg; 14 days, oral). 10
control rats received olive oil. Data are mean SD. a < 0.05.
Controls CSA
Creatinine clearance, mI/mm 1.5 0.1 0.9 0.Ia
CAT kidney cortex nmol/min/mg dry weight 55 6 72 33a
CAT urine nmol/min/mmol creatatinine 2.3 0.4 12 2.8a
Clinical Study: CAT was determined in 24 hour urine of 22 patients with
multiple sclerosis (MS) without renal disease treated by CSA >6
months. Group I (MS 1) had blood CSA 50 to 119 ng/ml; group 2 (MS
2) had CSA 120 to 180 ng/ml. Controls were 22 MS patients without
CSA. a p < 0.05 vs. controls. CAT in serum remained unchanged.
N
Cr
mi/mm
Cathepsin urine
nmol/min/mmo/
creat
Control 22 96 3 335 52
MSI 15 89±8 298±57
MS 2 7 79 5a 533 75
CSA increased CAT in kidney cortex and urine of rats. CAT was also
increased in urine of patients with blood CSA > 120 ng/ml. We
conclude that CSA may stimulate CAT in human kidney cortex as well.
Since CAT B + L are marker enzymes of lysosomal proteolysis,
increased intracellular protein degradation may be a side effect of CSA.
Effects of cyclosporine on lipid metabolism. F. W. Kemmer, J. Bloem,
P. Heering, T. Reinhard, and B. Grabensee, Departments of Medic mel
Nephroiogy and Ophthalmology, Heinrich-Heine Universitat, Düssel-
dorf, Germany. After successful transplantation hyperlipidemia can be
observed in many patients receiving immunosuppressive therapy with
corticosteroids, azathioprin and cyclosporine A (CsA). It is still a
matter of discussion whether CsA is a major cause of post-transplant
hyperlipidemia. Therefore, we have studied 10 healthy patients who
were treated with CsA for six months after ceratoplasty. Plasma lipids
and lipoproteins were measured before, during and two months after
CsA therapy. Patients receiving steroids or other lipoactive drugs were
excluded. All patients had normal liver and kidney function. The body
mass index was 24 4 and HbAIC was 5.2 0.4%. CsA trough levels
ranged between 80 and 150 ng/ml. Results:
Pre-CsA
2Mo+
CsA
6Mo+
CsA Post-CsA
Cholesterol mg/dL 223 36 240 47 247 56 225 52
HDL-Cholest mg/dl 50 17 53 15 58 28 59 25
LDL-Cholest mg/dL 149 28 163 45 147 69 141 30
Triglyceride mg/dL 164 81 168 75 197 174 159 97
Apo Al mg/dL 152 29 160 37 162 43 172 33
Apo-B mg/dL 121 27 128 35 134 49 123 37k'
Fibrinogen mg/dL 276 67 304 98 320 85 303 78
a differences statistically not significant.
HbAIC, uric acid, creatinine, BUN, ALT, AST and plasma viscosity
remained unchanged throughout the study. Conclusion: Six months of
CsA monotherapy did not induce significant increases in plasma levels
of cholesterol, triglycerides and lipoproteins after ceratoplasty. Thus,
CsA is unlikely to contribute markedly to the development of hyper-
lipidemia after organ transplantation.
Is the creatinine clearance a marker for GFR in renal graft recipients
treated with cyclosporin (CsA)? P. Heering and B. Grabensee, Heinrich
Heine University, Düsseldorf, Germany. The creatinine clearance is
widely applied to discover CsA-induced nephrotoxicity. There is a risk
of overestimation of the glomerular filtration rate (GFR) because of
tubular secretion of creatinine. We inhibited the tubular secretion of
creatinine by cimetidine. The creatinine clearance (Car) was studied
before and after administration of cimetidine in graft recipients treated
either with CsA (group I, N = 15) or azathioprine (group 2, N = 15).
The Cr decreased in group I from 69.3 5.7 mllmin/1 .73 m2 to 54.7
5.1 mI/mm (P < 0.05). The ratio of C. to C1 decreased from 1.08
0.03 to 0.95 0.04. The Cr in group 2 decreased during i.v. adminis-
tration of cimetidine from 73.9 5 mI/mm to 72.7 5.3 mI/mm. There
was only a slight change of the ratio of Cr to C1 from 1.0 0.03 to 0.98
0.04. Cimetidine reduced the difference between the C. and C1 as a
true filtration marker by blocking tubular secretion of creatinine. The
application of cimetidine improved the reliability of Cr as a measure of
GFR in CsA treated renal allograft recipients.
Cyclosporine or azathioprine following triple therapy? A prospective
randomized study. A. Westhoff, P. Heering, K. Ivens, M. Koch, and B.
Grabensee, Department of Nephrology, Heinrich-Heine-University,
Düsseldorf, Germany. Based on mostly uncontrolled studies it remains
unclear if stable post-transplant kidney function needs further immu-
nosuppression with the potential nephrotoxic cyclosporin (CsA) or if
azathioprine (Aza) combined with methylprednisolone (MP) represents
a safe alternative. Methods: Intended as a long-term prospective ran-
domized study, we investigated kidney function in 60/85 consecutive
transplanted patients (41 female, 40 male) after reduction of initial triple
immunosuppression (CsA/AzaJMP). Minimized therapy nine to 12
months after tx to CsA/MP (Group I) or AzaJMP (Group II) was
accompanied by a simultaneous short-time increase of the steroid with
optimizing the CsA blood concentration or Aza dosage respectively. 25
patients have been excluded from randomization because of transplant
failure or sensitivity to the side effects of the immunosuppressives.
Twenty-one patients (Group III) refused to participate in the study.
They served as a control group continuing triple therapy. Each clinical
decrease of transplant function has been examined by histological
investigation. Results: Group 1(12 f, 9 m): No rejection was seen after
reducing therapy to CsA. In eight patients a minimal loss of kidney
function developed. Mean creatinine before/after randomization: 1 .4
(0.9—2.2) versus 1.5 (0.8—2.6) mg/dl. Group 11(11 f, 7 m): With Aza
therapy 11/18 patients underwent marked interstitial and/or vascular
rejection episodes. Due to irreversible vascular rejection one patient
lost his graft. Mean creatinine before/after randomization: 1.4 (0.9—2.7)
versus 1.8 (0.9—4.1) mg/dl. Group III (6 f, 15 m): Under continued triple
therapy no patient developed transplant rejection after planned time of
randomization. Mean creatinine before/after planned randomization:
1.6(0.8—2.6) versus 1.5 (1.0—2.4) mg/dl. Conc!usion: In contrast to other,
mostly uncontrolled studies this investigation shows that reduction of
initial triple therapy with CsA to AzaJMP is a hazard to transplant
function. Therefore our study has been stopped.
Sequence specific targeting of the interleukin-2-receptor (IL2R) gene
expression with antisense oligonucleotides (ASON). Claudia Barth, W.
Maslinski, B. Zanker, TB. Strom, and C.A. Baldamus, Beth Israel
Hospital, Boston, Massachusetts, USA, and University Hospital KOIn,
Koln, Germany. ASON inhibit transcription by triplex formation with
the DNA helix and translation by duplex formation with mRNA. Our
aim was to determine whether ASON provide a new tool to abrogate
IL2Rgene expression. Specificly designed ASON were targeted against
exon 1 (El) and exon 3 (E3) of the p55 IL2R chain. Proliferation in
PHA-stimulated PBMC was significantly reduced to 14% (El) and 22%
(E3) of the total proliferative response. E3 diminished the amount of
IL2R mRNA by 35% (semiquantitative PCR). ASON successfully block
early, but transient transcribed genes (such as c-myc). The IL2R
undergoes later and prolonged gene activation. Therefore, no inhibition
of IL2R protein expression was seen (FACS), nor a truncated, func-
tionally impaired IL2R detected (epitope mapping, crosslinking study).
ASON, in addition, are rapidly degraded. To enhance the demonstrated
specific effect on IL2R gene expression modified nuclease resistant
ASON are required.
Expression of IL-2R and TNFo mRNA is increased in biopsies from
rejecting renal allografts (Tx). R. Schindler, Silvia Linnenweber, R.
Brunkhorst, K.-M. Koch, and U. Frei Department of Nephrology,
Medical School Hannover, Germany. Experimental studies in animals
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and clinical studies demonstrated the participation of cytokines during
rejection of Tx. However, the demonstration of cytokines in biological
fluids as a marker of rejection is hampered by inhibitors and binding
proteins; in previous studies, we found TNFa plasma levels not to be a
good indicator of rejection. We therefore investigated whether the local
gene expression of cytokines in Tx reflects histological and clinical
evidence for rejection. Renal tissue was obtained from two rejecting,
explanted Tx, from nine Tx-biopsies and from four tumor nephrecto-
mies as normal controls. Total RNA was extracted and analyzed for
cytokine mRNA by semiquantitative RT-PCR with /3-actin as the
internal control. Results:
n IL-2/IL-la IL-6/IL-l/3 TNFa IL-2R
TU 4 - + + -
Severe rejectiona 6 — + + i- + + + + + +
Mild rejectiona 3 — + + + —
a defined by histology.
Expression of IL-2R and TNFa mRNA in the graft is increased during
the course of rejection; besides conventional histology, the demonstra-
tion of different cytokine patterns in the graft may prove to be a useful
additional marker for rejection and might facilitate therapeutical deci-
sions.
Diagnostic value of interleukin-6 (IL-6) determinations in patients after
renal transplantation. Johannes E. Waiser, Kiemens Budde, and Hans-
Heilmut Neumayer, Department of Internal Medicine-Nephrology,
University Erlangen-Nurnberg, Germany. Cytokines are released by
graft-infiltrating cells during cellular rejection. We studied the release of
IL-6 and its prognostic significance in predicting rejection. Sequential
measurements were made in serum and urine samples with the IL-6-
specific cell line "B9." Biopsy tissue was snap frozen and examined
with immunohistochemistry. The IL-6 values for 21 normal controls
(CTR) and 86 healthy transplant patients (PTS) were 5 to 10 pg/mI in
serum and 0 to 5 pg/mI in urine. In 51 biopsy proven rejections, serum
IL-6 values at least doubled in 15 (sens. 29%, spec. 87%; 19 7 vs. 7
2 pg/mi; P = NS). In urine, an increase was observed in 29 of 36 PTS
(sens. 80%, spec. 75%; 92 34 vs. 5 I pg/mi; P < 0.05). After
treatment, IL-6 decreased in urine in 32/33 PTS to 7 2 pg/mI (P <
0.05). In three patients, rejection persisted, as did IL-6 urine values.
Further, in patients with urinary tract infections, IL-6 increased in the
serum of 13/19 and in the urine of 10/12. In tissue, IL-6 was found in the
interstitium of 21/21 (all) patients tested. Some biopsies additionally
showed weak staining of the tubular epithelium. The glomeruli were
negative. CTR tissue was negative. IL-6 in tissue could not be corre-
lated with IL-6 in serum or urine. We conclude: (1) serum IL-6 is of no
value in rejection; (2) urine IL-6 reflects rejection; however, infection
confounds the results; (3) IL-6 staining in tissue may be helpful, but
requires more study.
Isolated monocytes produce enhanced amounts of tumor necrosis factor
and interleukin-6 during chronic renal allograft rejection. S. Heidenre-
ich, J. Grout, D. Lang, M. Tepel, C. Spieker, and K.H. Rahn,
Department of Medicine D, University of Mflnster, Münster, Germany.
Chronic rejection (cr.) is the major problem for long-term renal
allograft survival. The importance of immune processes for progression
of cr. remains unclear. Here, we investigated basal and LPS-triggered
tumor necrosis factor (TNF-cs) and interieukin-6 (IL-6) production by
isolated monocytes (MØ) in vitro from 17 patients with histologically
confirmed cr. and for control from 22 kidney transplant patients with
stable function (s.f.). Basal TNF-a formation of 0.7 1.8 ng/ml was
elevated to 11.5 14.6 ng/ml TNF-a by 100 ng/ml LPS during s.f. In
cr. group, significant higher amounts were found: basal 7.0 24.1
ng/ml TNF-a and LPS-triggered 154.9 242.7 ng/ml TNF-s (P <
0.001). Similarly, LPS-triggered IL-6 formation was increased in c.r.
patients: 33.12 12.85 ng/ml IL-6 versus 12.08 12.50 ng/ml IL-6 in
s.f. (P < 0.01). Additional stimulation of LPS-triggered MØ by 25 U/mI
interferon-y(IFN-y) enhanced TNF-a synthesis by 67% in s.f. patients,
but not during c.r., where a slight reduction of TNF-a formation was
observed. This indicates that T cell products might be responsible for
immune stimulation during c.r. Supplementation of MØ cultures with
10—6 M prednisolone reduced in some but not all patients with c.r.
monokine synthesis so that the presented in vitro test system might be
suitable to select between patients who profit or not by an intensified
immunosuppressive treatment. We conclude that immune processes are
involved in development of chronic renal graft rejection and should be
specifically blocked to prevent progression.
A new mode of examination for increasing sensitivity and specificity of
the detection of renal transplant rejection by dopplersonography. M.
Hollenbeck and B. Grabensee, Department of Nephrology, Heinrich-
Heine University Düsseldorf, Düsseldorf, Germany. During renal trans-
plant rejection, alterations of renal arterial flow pattern were described.
A wide variation exists in the literature concerning the sensitivity and
specificity of dopplersonography in the detection of rejection. In a
second of following rejection, dopplersonography seems to have a
diminished value. In a prospective study we evaluated the specificity in
the detection of a first rejection (REJ) with a given sensitivity of 90% as
it should be demanded for a screening test. Analyzed markers were the
resistive index (RI), the relative increase of RI regarding to the
preceeding value (REL-RI), the Pulsatility Index (P1) and its relative
increase (REL-PI). Materials and Methods: In 65 patients 330 color
coded dopplersonographic examinations were done routinely within an
interval of two to four days (QAD 1, Philips Medical Systems, Ham-
burg, Germany) after transplantation until discharge or, if it happened,
until a second rejection. Each time, at least three profiles were recorded
in interlobular arteries and RI and P1 were calculated. Results: 36 of 41
REJ showed an increase of RI 2.9 days in average before the clinical!
histological diagnosis of REJ. Increasing P1 was seen in 38 of4l REJ 3.3
days before. For the demanded sensitivity of 90% the analysis of all 330
flow profils resulted in a speciticity of 30% for a cutoff-threshold RI of
0.73 and a speciticity of 42% for a cutoff-threshold P1 of 1.5. Looking to
the intraindividual course there was a speciticity of 47% for a cutoff-
threshold REL-RI of 0.1% increase/day and a speciticity of 73% for a
threshold REL-PI of 2.6% increase/day. Conclusions: The specificity of
detecting a first renal transplant rejection by dopplersonography can be
improved by looking to the intraindividual course of the P1 with a two
to four day interval between examinations. The REL-PI is superior to
REL-RI mainly because increasing flow resistance in grafts without
diastolic blood flow, as in postischemic acute renal failure, can be
detected with P1 and not with RI. With this mode of examination
transplant rejection could be detected in average three days before the
clinical or histological diagnosis of rejection. We believe that biopsy in
grafts with increasing P1 can detect rejection in an earlier state so that
organ damage can be reduced.
Antigenemia, immunoblotting and enzyme Immunoassay for early
diagnosis of cytomegalovirus (CMV) infection (IN) in renal transplant
patients (RTP). G. Leimenstoll, L. Fischer, P. Rautenberg, H. Bienen-
graber, R. Engemann, and W. Niedermayer, Department of Nephrol-
ogy, University of Kiel, Germany. Timely and rapid diagnosis of CMV
IN is important in RTP. We compared the values of three serological
assays/IgM immunoblot (IB) and IgG/IgM ELISA) with the detection of
immediate early antigen (IEA/p65 lower matrix protein) in blood
leukocytes for diagnosis of CMV IN. Thirty-one RTP were monitored
for three months. CMV IN was demonstrated in 18 RTP; sensitivity was
100% for 1gM lB. 86% for IgG ELISA, 59% for lEA, and 54% for 1gM
ELISA. Ten patients developed symptomatic CMV INs which were
detected in 100% by 1gM lB and IgG ELISA, in 90% by lEA, and in
70% by 1gM ELISA. The lEA test indicated CMV INs significantly
earlier than lB and ELISA (P < 0.05). In symptomatic patients CMV
lEA positive leukocytes were detected, on average, on the day of onset
of symptoms whereas 1gM IB, IgG ELISA followed about eight, 13, and
14 days later respectively. These results show that: (1) the CMV lEA
test is very useful for early diagnosis of symptomatic CMV INs; (2) that
CMV antibodies as indicator of CMV IN are detectable earlier and with
a higher sensitivity by 1gM lB than by IgG/IgM ELISA; (3) the best
serological test (1gM immunoblot) compared with the CMV lEA test
has a higher sensitivity but detects CMV IN significantly later (4).
Kidney transplantation in children with severe steroid resistant ne-
phrotic syndrome. J.H.H. Ehrich, Chantal Loirat, and E. Albert, EDTA
Registry, London, Medizinische Hochschule Hannover, Hôpital
Necker Paris, and University of Munich, Munich, Germany. The
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course of severe nephrotic syndrome after start of renal replacement
therapy (RRT) was studied in 215 children reported to the EDTA
Registry. One hundred seventy-six children had focal glomerulosciero-
sis (FSGS), 29 had diffuse mesangial proliferation (DMP), and 10 had
minimal lesions (ML). In FSGS, the mean age at onset of nephrotic
syndrome (NS) was 5.6 years, at biopsy 6.8 years, at start of RRT 9.6
years and at first transplantation 11.1 years. In patients with FSGS,
recurrence of nephrotic syndrome occurred in 27% of patients with a
first graft and in 36% of patients with a second graft. Four percent of
patients with a first graft and 6% with a 2nd graft showed FSGS on
biopsy without recurrence of NS. Recurrence of NS in patients with
DMP and ML was in the same order. Regarding the factors for
prediction of recurrence, fewer children <6 years at grafting for FSGS
showed a recurrence than children >6 years (24% vs. 36%). Recurrence
of NS was not significantly different in cadaveric and living donor
grafts. Neither the HLA type of the patient nor of the donor correlated
significantly with the recurrence of NS. There was also no influence of
the HLA match on the recurrence of NS. At onset of recurrent NS,
median serum creatinine was almost normal. Twenty-five percent of
patients lost their graft due to recurrence of NS (median interval until
graft loss = 5 months). The type of immunosuppression had no major
influence on the recurrence rate. Patient survival after renal transplan-
tation of children with FSOS, DMP or ML did not differ significantly in
patients with and without recurrent NS. First graft survival was mildly
reduced in patients with recurrence of NS.
Incidence and prognosis of recurrent and de novo glomerulonephritis
after renal transplantation. Mirjam Kienbaum, Matthias Schreiber,
Roland Schmieder, and Hans-Helimut Neumayer, Department of In-
ternal Medicine-Nephrology, University Erlangen-Nurnberg, Ger-
many. We analyzed 473 biopsies from 323 patients representing 785
consecutive patients transplanted between 1980—90 to determine the
incidence and clinical course of post-transplant glomerulonephritis
(GN). Glomerular disease was found in 131(40.6%) of the 473 biopsies.
Glomerulonephritis was established in 49 patients, representing 6.2% of
the population and 15.2% of the biopsies. Membranous (MGN) was
found in 18, focal sclerosis (FSCN) in 10, mesangioproliferative (Mes-
ON) in nine, membranoproliferative (MPGN) in three, and rapidly
progressive (RPGN) in two patients. Six biopsies defied classification.
Sixteen patients had not had GN before transplant (de novo GN), while
six patients had a recurrence of a previous GN. Transplant nephropathy
was diagnosed in 21 patients, four had diabetic glomenilosclerosis, and
57 patients had "nonspecific" glomerular changes. Patients with ON
had proteinuria> 3 glday, an accelerated increase in creatinine, and an
increase in graft loss (52% vs. 22%; P < 0.05) compared to patients
without ON. MGN had only a 23% graft survival at five years (P <
0.05), while patients with "nonspecific" glomerular lesions had a graft
survival of 33% at five years (P <0.05). Biopsied patients had a reduced
graft survival compared to nonbiopsied patients (20% vs. 60% at 10
years; P < 0.05). However, the prognosis of patients with ON was not
worse than that of biopsied patients with other findings (44% vs. 35%).
Our data confirm the adverse effect of GN on transplant survival. The
risk is similar to that of graft rejection. Nevertheless, with a graft
survival rate of 44% at five years, we feel that transplantation is a
desirable alternative even for these high risk patients.
